Rank;Sourceid;Title;Type;Issn;SJR;SJR Best Quartile;H index;Total Docs. (2007);Total Docs. (3years);Total Refs.;Total Cites (3years);Citable Docs. (3years);Cites / Doc. (2years);Ref. / Doc.;Country;Publisher;Coverage;Categories
1;19479;Annual Review of Pharmacology and Toxicology;journal;15454304, 03621642;11,263;Q1;193;24;69;3600;1543;69;22,28;150,00;United States;Annual Reviews Inc.;1965-1973, 1975-ongoing;"Pharmacology (Q1); Toxicology (Q1)"
2;21191;Pharmacological Reviews;journal;15210081, 00316997;9,450;Q1;210;19;85;4334;1562;81;17,85;228,11;United States;American Society for Pharmacology and Experimental Therapeutics;1949-ongoing;"Molecular Medicine (Q1); Pharmacology (Q1)"
3;20425;Nature Reviews Drug Discovery;journal;14741776;7,774;Q1;289;155;819;6695;4888;285;16,02;43,19;United Kingdom;Nature Publishing Group;2002-ongoing;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
4;24032;Reviews of Physiology Biochemistry and Pharmacology;book series;03034240;4,568;Q1;58;0;32;0;200;32;5,44;0,00;Germany;Springer Verlag;1974-2008, 2012-ongoing;"Biochemistry (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Physiology (Q1); Physiology (medical) (Q1)"
5;22321;Trends in Pharmacological Sciences;journal;01656147;4,509;Q1;201;95;318;5097;2864;293;9,41;53,65;Netherlands;Elsevier BV;1979-ongoing;"Pharmacology (Q1); Toxicology (Q1)"
6;21195;Pharmacology and Therapeutics;journal;01637258;3,796;Q1;180;99;265;16261;2285;259;8,29;164,25;United Kingdom;Elsevier Ltd.;1975-1977, 1979-1985, 1987-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
7;13903;Cellular and Molecular Life Sciences;journal;1420682X, 14209071;3,265;Q1;194;266;769;24269;4117;762;5,28;91,24;Switzerland;Birkhauser Verlag;1997-ongoing;"Cell Biology (Q1); Cellular and Molecular Neuroscience (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
8;18017;Neuropsychopharmacology;journal;0893133X;3,143;Q1;204;248;797;14745;4696;749;5,89;59,46;United Kingdom;Nature Publishing Group;1987-ongoing;"Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
9;19409;Advanced Drug Delivery Reviews;journal;0169409X;3,073;Q1;278;110;373;11765;3085;304;8,92;106,95;Netherlands;Elsevier BV;1987-ongoing;Pharmaceutical Science (Q1)
10;20681;Current Opinion in Pharmacology;journal;14714892;3,033;Q1;120;107;301;4920;1919;267;6,90;45,98;Netherlands;Elsevier BV;2001-ongoing;"Drug Discovery (Q1); Pharmacology (Q1)"
11;12611;Drug Resistance Updates;journal;13687646, 15322084;2,935;Q1;100;13;78;1758;548;75;6,72;135,23;United States;Churchill Livingstone;1998-ongoing;"Cancer Research (Q1); Infectious Diseases (Q1); Oncology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
12;29311;Current Cancer Drug Targets;journal;15680096;2,814;Q1;85;73;139;8100;754;135;5,71;110,96;United Arab Emirates;Bentham Science Publishers;2001-ongoing;"Cancer Research (Q1); Drug Discovery (Q1); Pharmacology (Q1)"
13;21100456838;Cell Chemical Biology;journal;24519448, 24519456;2,798;Q1;166;162;570;5752;2563;525;4,61;35,51;United States;Elsevier Inc.;2016-ongoing;"Biochemistry (Q1); Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
14;26371;Natural Product Reports;journal;02650568, 14604752;2,741;Q1;157;72;146;10715;911;136;6,60;148,82;United Kingdom;Royal Society of Chemistry;1984-ongoing;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
15;19907;Medicinal Research Reviews;journal;01986325, 10981128;2,645;Q1;119;27;81;4465;609;79;7,04;165,37;United States;John Wiley & Sons Inc.;1981-ongoing;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
16;18148;Pain;journal;03043959;2,597;Q1;238;287;1007;10449;5273;840;5,93;36,41;United States;Lippincott Williams & Wilkins Ltd.;1975-ongoing;"Anesthesiology and Pain Medicine (Q1); Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1)"
17;15984;Journal of Molecular Medicine;journal;09462716, 14321440;2,568;Q1;127;138;338;6690;1612;315;4,83;48,48;Germany;Springer Verlag;1976-1978, 1980-1981, 1995-ongoing;"Drug Discovery (Q1); Genetics (clinical) (Q1); Molecular Medicine (Q1)"
18;5100155080;Neurotherapeutics;journal;19337213;2,567;Q1;100;77;162;5061;994;146;6,17;65,73;United States;Springer New York LLC;2007-ongoing;"Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
19;19963;Molecular Pharmacology;journal;15210111, 0026895X;2,555;Q1;186;362;1229;14069;5700;1205;4,53;38,86;United States;American Society for Pharmacology and Experimental Therapeutics;1965-ongoing;"Molecular Medicine (Q1); Pharmacology (Q1)"
20;12455;Molecular Therapy;journal;15250024, 15250016;2,487;Q1;158;272;710;11358;3824;648;5,97;41,76;United States;Cell Press;2000-ongoing;"Drug Discovery (Q1); Genetics (Q1); Medicine (miscellaneous) (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
21;21000196010;Topics in antiviral medicine;journal;21615853;2,407;Q1;37;16;54;41;206;54;3,95;2,56;United States;International Antiviral Society;2011-ongoing;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Virology (Q1)"
22;23010;Journal of Controlled Release;journal;01683659;2,168;Q1;237;278;1080;11157;4935;1063;4,15;40,13;Netherlands;Elsevier BV;1984-ongoing;Pharmaceutical Science (Q1)
23;19615;Antimicrobial Agents and Chemotherapy;journal;10986596, 00664804;2,167;Q1;232;592;2313;16636;10438;2184;4,71;28,10;United States;American Society for Microbiology;1963-1970, 1972-ongoing;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
24;23041;Journal of Medicinal Chemistry;journal;00222623, 15204804;2,119;Q1;240;694;2502;28163;12094;2467;4,74;40,58;United States;American Chemical Society;1963-ongoing;"Drug Discovery (Q1); Molecular Medicine (Q1)"
25;20626;Clinical Pharmacology and Therapeutics;journal;00099236;2,103;Q1;173;248;437;7162;2488;335;7,14;28,88;United States;Wiley-Blackwell;1960-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
26;26795;Controlled Clinical Trials;journal;01972456;2,100;Q1;70;0;47;0;197;40;0,00;0,00;Netherlands;Elsevier BV;1980-2004;Pharmacology (Q1)
27;110112;Journal of immunotherapy (Hagerstown, Md. : 1997);journal;15249557;2,060;Q1;89;90;175;3840;830;172;4,84;42,67;United States;Lippincott Williams & Wilkins Ltd.;1994-ongoing;"Cancer Research (Q1); Immunology (Q1); Immunology and Allergy (Q1); Pharmacology (Q1)"
28;4500151409;CNS and Neurological Disorders - Drug Targets;journal;18715273;2,059;Q1;78;46;163;6068;739;147;4,64;131,91;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q1); Neuroscience (miscellaneous) (Q1); Pharmacology (Q1)"
29;16876;Bioconjugate Chemistry;journal;15204812, 10431802;2,052;Q1;161;286;608;10169;2774;601;4,29;35,56;United States;American Chemical Society;1990-ongoing;"Bioengineering (Q1); Biomedical Engineering (Q1); Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
30;21782;Psychopharmacology;journal;00333158;2,029;Q1;181;308;1166;17017;4834;1113;4,07;55,25;Germany;Springer Verlag;1959-ongoing;Pharmacology (Q1)
31;20435;Neuropharmacology;journal;00283908;1,935;Q1;150;266;746;13131;2872;736;3,24;49,36;United Kingdom;Elsevier Ltd.;1962-ongoing;"Pharmacology (Q1); Cellular and Molecular Neuroscience (Q2)"
32;24661;Critical Reviews in Toxicology;journal;15476898, 10408444;1,915;Q1;98;31;78;4631;414;71;5,41;149,39;United Kingdom;Taylor & Francis;1971-ongoing;Toxicology (Q1)
33;26380;Drug and Alcohol Dependence;journal;03768716;1,849;Q1;151;264;523;11687;1965;508;3,50;44,27;Netherlands;Elsevier BV;1975-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
34;23916;Environmental Pollution;journal;02697491, 18736424;1,843;Q1;194;414;999;17992;3451;987;3,22;43,46;United Kingdom;Elsevier Ltd.;1970-1980, 1986-ongoing;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Pollution (Q1); Toxicology (Q1)"
35;29318;Anti-Cancer Agents in Medicinal Chemistry;journal;18715206, 18755992;1,839;Q1;82;43;136;6066;664;129;6,05;141,07;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Cancer Research (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
36;23488;Current Medicinal Chemistry;journal;09298673;1,834;Q1;158;255;625;33996;3279;602;5,04;133,32;United Arab Emirates;Bentham Science Publishers;1994-ongoing;"Molecular Medicine (Q1); Pharmacology (Q1)"
37;22452;International Journal of Neuropsychopharmacology;journal;14611457, 14695111;1,818;Q1;93;66;241;4454;823;201;3,73;67,48;United Kingdom;Oxford University Press;1998-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
38;4400151524;Particle and Fibre Toxicology;journal;17438977;1,812;Q1;83;11;30;555;208;29;7,33;50,45;United Kingdom;BioMed Central;2004-ongoing;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
39;145164;Human Genomics;journal;14739542, 14797364;1,791;Q1;49;0;92;0;256;78;2,79;0,00;United Kingdom;BioMed Central;2003-2006, 2008-ongoing;"Drug Discovery (Q1); Genetics (Q1); Molecular Medicine (Q1); Molecular Biology (Q2)"
40;12331;Current Topics in Medicinal Chemistry;journal;15680266;1,782;Q1;104;136;410;10386;1641;348;4,64;76,37;United Arab Emirates;Bentham Science Publishers;2001-ongoing;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1)"
41;20682;Current Pharmaceutical Design;journal;13816128;1,781;Q1;140;287;1031;33661;4478;915;5,10;117,29;United Arab Emirates;Bentham Science Publishers;1995-ongoing;"Drug Discovery (Q1); Pharmacology (Q1)"
42;22418;Journal of Antimicrobial Chemotherapy;journal;03057453, 14602091;1,744;Q1;172;459;1283;10837;4799;1068;4,56;23,61;United Kingdom;Oxford University Press;1975-ongoing;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
43;20084;British Journal of Pharmacology;journal;00071188;1,728;Q1;190;379;1207;17413;4529;1165;3,64;45,94;United States;Wiley-Blackwell;1958, 1965-ongoing;Pharmacology (Q1)
44;21790;Antiviral Therapy;journal;13596535;1,704;Q1;78;136;378;5741;1474;359;3,89;42,21;United Kingdom;International Medical Press;1996-ongoing;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
45;23086;Journal of Pharmacology and Experimental Therapeutics;journal;15210103, 00223565;1,697;Q1;209;516;1907;19354;7501;1879;4,00;37,51;United States;American Society for Pharmacology and Experimental Therapeutics;1945-ongoing;"Molecular Medicine (Q1); Pharmacology (Q1)"
46;20063;Biochemical Pharmacology;journal;00062952;1,692;Q1;181;352;1204;16757;4728;1136;4,29;47,61;Netherlands;Elsevier BV;1958-ongoing;"Biochemistry (Q1); Pharmacology (Q1)"
47;18403;Apoptosis : an international journal on programmed cell death;journal;13608185, 1573675X;1,666;Q1;102;173;384;9551;1352;379;3,25;55,21;Netherlands;Kluwer Academic Publishers;1996-ongoing;"Biochemistry (medical) (Q1); Clinical Biochemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Cancer Research (Q2); Cell Biology (Q2)"
48;26512;Tetrahedron;journal;00404020;1,648;Q1;209;1277;3712;62685;10452;3657;2,81;49,09;United Kingdom;Elsevier Ltd.;1957-ongoing;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
49;15576;European Neuropsychopharmacology;journal;0924977X;1,623;Q1;100;101;261;4797;1028;254;4,14;47,50;Netherlands;Elsevier BV;1990-ongoing;"Biological Psychiatry (Q1); Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
50;24649;Chemical Research in Toxicology;journal;15205010, 0893228X;1,601;Q1;144;213;617;9223;2230;600;3,60;43,30;United States;American Chemical Society;1988-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
51;20659;Critical Reviews in Therapeutic Drug Carrier Systems;journal;07434863;1,517;Q1;69;14;36;1996;145;36;2,46;142,57;United States;Begell House;1984-ongoing;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
52;21332;European Journal of Pharmaceutics and Biopharmaceutics;journal;09396411;1,505;Q1;138;192;407;6047;1478;400;2,88;31,49;Netherlands;Elsevier BV;1991-ongoing;"Biotechnology (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1)"
53;18922;Journal of Gene Medicine;journal;1099498X, 15212254;1,492;Q1;87;106;441;4148;1751;437;3,62;39,13;United States;John Wiley & Sons Inc.;1998-ongoing;"Drug Discovery (Q1); Molecular Medicine (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Biology (Q2)"
54;28792;Cancer Biology and Therapy;journal;15384047;1,489;Q1;101;314;989;10475;1739;630;2,79;33,36;United States;Landes Bioscience;2002-ongoing;"Oncology (Q1); Pharmacology (Q1); Cancer Research (Q2); Molecular Medicine (Q2)"
55;12584;Drug Metabolism Reviews;journal;10979883, 03602532;1,488;Q1;89;44;115;3050;512;112;3,91;69,32;United States;Marcel Dekker Inc.;1972-ongoing;"Pharmacology (medical) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
56;16088;Journal of Nanobiotechnology;journal;14773155;1,469;Q1;57;9;34;360;187;34;3,23;40,00;United Kingdom;BioMed Central;2003-ongoing;"Applied Microbiology and Biotechnology (Q1); Bioengineering (Q1); Biomedical Engineering (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Molecular Medicine (Q2); Nanoscience and Nanotechnology (Q2)"
57;20677;Current Opinion in Drug Discovery and Development;journal;13676733;1,460;Q1;75;77;206;3851;765;191;3,85;50,01;United Kingdom;Current Drugs Ltd.;1998-2010;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
58;25218;Toxicological Sciences;journal;10960929, 10966080;1,459;Q1;164;324;975;14112;3817;924;3,91;43,56;United Kingdom;Oxford University Press;1981-ongoing;Toxicology (Q1)
59;26514;Tetrahedron Letters;journal;00404039;1,448;Q1;159;1832;6099;55634;15309;6019;2,57;30,37;United Kingdom;Elsevier Ltd.;1959-ongoing;"Drug Discovery (Q1); Organic Chemistry (Q1); Biochemistry (Q2)"
60;22072;Current Gene Therapy;journal;15665232;1,447;Q1;65;41;145;4262;638;139;4,92;103,95;United Arab Emirates;Bentham Science Publishers;2001-ongoing;"Drug Discovery (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
61;20664;Current Drug Targets;journal;13894501;1,433;Q1;92;125;325;14275;1232;289;4,31;114,20;United Arab Emirates;Bentham Science Publishers;2000-ongoing;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
62;21354;Expert Opinion on Therapeutic Targets;journal;14728222;1,433;Q1;78;126;230;12283;693;212;3,34;97,48;United Kingdom;Taylor & Francis;1997-ongoing;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
63;4000148203;Handbook of Experimental Pharmacology;book series;01712004;1,431;Q1;81;87;213;7670;614;204;3,02;88,16;Germany;Springer Verlag;2005-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry (Q2)"
64;20624;Clinical Pharmacokinetics;journal;03125963;1,429;Q1;150;63;237;4183;1194;226;4,93;66,40;United Kingdom;Adis International Ltd.;1976-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
65;24791;Alcoholism: Clinical and Experimental Research;journal;01456008, 15300277;1,417;Q1;143;256;806;12190;2531;783;3,16;47,62;United States;Wiley-Blackwell;1977-ongoing;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
66;23109;Journal of Psychopharmacology;journal;02698811;1,415;Q1;106;110;335;4785;1026;289;3,46;43,50;United States;SAGE Publications;1987-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
67;21226;Drug Metabolism and Disposition;journal;00909556, 1521009X;1,414;Q1;161;305;739;9681;2893;715;3,75;31,74;United States;American Society for Pharmacology and Experimental Therapeutics;1973-ongoing;"Pharmaceutical Science (Q1); Pharmacology (Q1)"
68;4400151701;Journal of Exposure Science and Environmental Epidemiology;journal;1559064X, 15590631;1,409;Q1;81;97;188;3069;501;177;3,11;31,64;United Kingdom;Nature Publishing Group;2006-ongoing;"Pollution (Q1); Public Health, Environmental and Occupational Health (Q1); Toxicology (Q1); Epidemiology (Q2)"
69;25222;Toxicology and Applied Pharmacology;journal;10960333, 0041008X;1,407;Q1;153;286;862;13742;3347;848;3,46;48,05;United States;Elsevier Inc.;1959-ongoing;"Pharmacology (Q1); Toxicology (Q1)"
70;20758;Current Drug Targets: Inflammation and Allergy;journal;1568010X;1,399;Q1;48;0;145;0;529;132;4,22;0,00;United Arab Emirates;Bentham Science Publishers;2002-2005;"Immunology and Allergy (Q1); Pharmacology (Q1); Immunology (Q2)"
71;20663;Current Drug Metabolism;journal;13892002;1,367;Q1;97;67;150;7295;777;144;4,69;108,88;United Arab Emirates;Bentham Science Publishers;2000-ongoing;"Clinical Biochemistry (Q1); Pharmacology (Q1)"
72;21123;Pharmaceutical Research;journal;07248741, 1573904X;1,363;Q1;191;219;771;10421;2741;762;3,26;47,58;United States;Kluwer Academic/Plenum Publishers;1984-ongoing;"Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Molecular Medicine (Q2)"
73;23155;Current Vascular Pharmacology;journal;15701611;1,362;Q1;54;25;116;2508;432;111;4,34;100,32;United Arab Emirates;Bentham Science Publishers;2003-ongoing;"Cardiology and Cardiovascular Medicine (Q1); Pharmacology (Q1)"
74;21196;Drug Discovery Today;journal;13596446;1,362;Q1;157;135;766;6840;2483;631;4,47;50,67;Netherlands;Elsevier BV;1996-ongoing;"Drug Discovery (Q1); Pharmacology (Q1)"
75;7000153203;Journal of Studies on Alcohol and Drugs;journal;19371888, 19384114;1,356;Q1;116;91;342;3645;847;324;2,40;40,05;United States;Center of Alcohol Studies, Rutgers, The State University of New Jersey;2007-ongoing;"Health (social science) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
76;29845;IARC Monographs on the Evaluation of Carcinogenic Risks to Humans;journal;10171606;1,335;Q1;38;14;27;4907;86;27;1,00;350,50;France;International Agency for Research on Cancer;1988-1997, 1999-2002, 2004, 2006-2008, 2010-ongoing;"Toxicology (Q1); Cancer Research (Q2)"
77;21168;Pharmacogenomics Journal;journal;1470269X, 14731150;1,305;Q1;78;42;155;2467;693;140;5,40;58,74;United Kingdom;Nature Publishing Group;2001-ongoing;"Pharmacology (Q1); Genetics (Q2); Molecular Medicine (Q2)"
78;20104;CNS Drug Reviews;journal;1080563X, 15273458;1,292;Q1;52;22;58;1817;204;56;3,71;82,59;United States;Neva Press, Inc.;1996-2007;"Pharmacology (Q1); Neuropsychology and Physiological Psychology (Q2)"
79;21767;Progress in Neuro-Psychopharmacology and Biological Psychiatry;journal;02785846;1,291;Q1;114;278;555;11293;1731;524;3,29;40,62;Netherlands;Elsevier BV;1982-ongoing;"Pharmacology (Q1); Biological Psychiatry (Q2)"
80;130126;Molecular Pharmaceutics;journal;15438384, 15438392;1,277;Q1;110;96;190;4563;711;180;4,01;47,53;United States;American Chemical Society;2004-ongoing;"Drug Discovery (Q1); Pharmaceutical Science (Q1); Molecular Medicine (Q2)"
81;23053;Journal of Natural Products;journal;01633864, 15206025;1,255;Q1;124;368;1247;9104;3258;1214;2,62;24,74;United States;American Chemical Society;1949, 1971, 1973, 1978-ongoing;"Analytical Chemistry (Q1); Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
82;25125;Journal of Analytical Toxicology;journal;01464760;1,252;Q1;69;81;362;1794;823;345;2,26;22,15;United States;Perston Publications, Inc.;1977-ongoing;"Analytical Chemistry (Q1); Chemical Health and Safety (Q1); Environmental Chemistry (Q1); Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
83;29712;Clinical Therapeutics;journal;01492918;1,247;Q1;123;293;585;9522;2235;509;4,13;32,50;United States;Elsevier Inc.;1977-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
84;21237;Drug Safety;journal;01145916;1,235;Q1;115;100;274;4881;1017;248;3,96;48,81;United Kingdom;Adis International Ltd.;1990-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1)"
85;4100151708;Inflammation and Allergy - Drug Targets;journal;18715281;1,235;Q1;42;28;25;2434;66;22;3,00;86,93;United Arab Emirates;Bentham Science Publishers;2006-2015;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Immunology (Q2); Immunology and Allergy (Q2)"
86;23061;Journal of Pharmaceutical and Biomedical Analysis;journal;07317085;1,222;Q1;114;539;1337;13689;3677;1317;2,74;25,40;Netherlands;Elsevier BV;1983-ongoing;"Analytical Chemistry (Q1); Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmaceutical Science (Q1); Spectroscopy (Q2)"
87;23079;Journal of Pharmaceutical Sciences;journal;00223549;1,200;Q1;159;261;787;10890;2346;734;3,15;41,72;United States;Elsevier Inc.;1961-ongoing;Pharmaceutical Science (Q1)
88;20049;Behavioural Pharmacology;journal;14735849, 09558810;1,194;Q1;76;70;218;3956;517;208;2,28;56,51;United States;Lippincott Williams & Wilkins Ltd.;1992-ongoing;"Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
89;21351;Expert Opinion on Investigational Drugs;journal;13543784;1,190;Q1;94;172;418;12057;1386;390;3,75;70,10;United Kingdom;Taylor & Francis;1994-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
90;22454;International Journal of Pharmaceutics;journal;03785173;1,186;Q1;190;510;1400;15823;4117;1380;2,63;31,03;Netherlands;Elsevier BV;1978-ongoing;Pharmaceutical Science (Q1)
91;25789;Bioorganic Chemistry;journal;00452068, 10902120;1,164;Q1;50;36;116;1331;262;112;2,09;36,97;United States;Elsevier Inc.;1971-ongoing;"Drug Discovery (Q1); Organic Chemistry (Q1); Biochemistry (Q2); Molecular Biology (Q3)"
92;4600151527;Infectious Disorders - Drug Targets;journal;18715265;1,158;Q1;49;32;81;3529;233;76;3,09;110,28;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q1); Microbiology (medical) (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
93;4700152457;Nano Today;journal;17480132;1,149;Q1;119;40;25;1794;70;16;4,38;44,85;Netherlands;Elsevier BV;2006-ongoing;"Biomedical Engineering (Q1); Biotechnology (Q1); Materials Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Bioengineering (Q2); Nanoscience and Nanotechnology (Q2)"
94;24749;Addiction Biology;journal;13556215, 13691600;1,142;Q1;70;36;113;2655;294;99;2,86;73,75;United States;Wiley-Blackwell;1996-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
95;22477;Investigational New Drugs;journal;01676997, 15730646;1,131;Q1;80;73;186;1876;532;180;3,17;25,70;Netherlands;Kluwer Academic Publishers;1983-ongoing;"Oncology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
96;21165;PharmacoEconomics;journal;11707690;1,129;Q1;91;72;357;3206;900;306;2,76;44,53;United Kingdom;Adis International Ltd.;1992-ongoing;"Health Policy (Q1); Pharmacology (Q1); Public Health, Environmental and Occupational Health (Q1)"
97;25788;Bioorganic and Medicinal Chemistry Letters;journal;14643405, 0960894X;1,126;Q1;133;1189;3562;29393;8610;3515;2,50;24,72;United Kingdom;Elsevier Ltd.;1991-ongoing;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Biochemistry (Q2); Molecular Medicine (Q2); Molecular Biology (Q3)"
98;144771;Clinical Trials;journal;17407753, 17407745;1,119;Q1;55;61;179;1519;270;162;1,67;24,90;United States;SAGE Publications;2004-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
99;24797;Mini-Reviews in Medicinal Chemistry;journal;13895575;1,113;Q1;79;108;331;11054;1064;313;3,18;102,35;United Arab Emirates;Bentham Science Publishers;2001-ongoing;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
100;21197;Pharmacology Biochemistry and Behavior;journal;00913057;1,095;Q1;126;176;816;9717;1975;812;2,37;55,21;United States;Elsevier Inc.;1973-ongoing;"Pharmacology (Q1); Toxicology (Q1); Biochemistry (Q2); Biological Psychiatry (Q2); Clinical Biochemistry (Q2); Behavioral Neuroscience (Q3)"
101;24603;Archives of Environmental Contamination and Toxicology;journal;14320703, 00904341;1,094;Q1;98;153;430;6149;783;428;1,66;40,19;Germany;Springer Verlag;1973-ongoing;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Pollution (Q1); Toxicology (Q1)"
102;13250;Expert Opinion on Biological Therapy;journal;14712598;1,092;Q1;75;147;429;12414;1257;425;2,79;84,45;United Kingdom;Taylor & Francis;2001-ongoing;"Drug Discovery (Q1); Pharmacology (Q1); Clinical Biochemistry (Q2)"
103;23085;Journal of Pharmacological Sciences;journal;13478648, 13478613;1,089;Q1;74;167;567;5227;1422;551;2,64;31,30;Netherlands;Elsevier BV;1996-ongoing;"Pharmacology (Q1); Molecular Medicine (Q2)"
104;18071;Neurotoxicity Research;journal;10298428;1,087;Q1;65;46;163;4442;498;162;3,31;96,57;United States;Springer New York LLC;2001-ongoing;"Toxicology (Q1); Neuroscience (miscellaneous) (Q2)"
105;24763;Addictive Behaviors;journal;03064603;1,083;Q1;114;297;589;8857;1386;585;2,05;29,82;United Kingdom;Elsevier Ltd.;1975-ongoing;"Clinical Psychology (Q1); Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
106;25152;Journal of Toxicology and Environmental Health - Part B: Critical Reviews;journal;10937404, 15216950;1,083;Q1;70;17;55;3595;183;50;2,85;211,47;United Kingdom;Taylor & Francis;1998-ongoing;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
107;84948;Expert Opinion on Drug Delivery;journal;17425247;1,077;Q1;88;52;153;3861;457;143;2,98;74,25;United Kingdom;Taylor & Francis;2004-ongoing;Pharmaceutical Science (Q1)
108;21825;Reviews in Contemporary Pharmacotherapy;journal;09548602;1,077;Q1;16;0;1;0;2;1;0,00;0,00;United Kingdom;Marius Press;1996-2004;Pharmacology (Q1)
109;27823;Alimentary Pharmacology and Therapeutics, Supplement;journal;09530673;1,069;Q1;62;0;184;0;595;177;2,97;0,00;United Kingdom;Blackwell Publishing Inc.;1991, 1993-2005;"Pharmacology (medical) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
110;19617;Antiviral Research;journal;01663542;1,064;Q1;108;109;289;4220;940;285;3,53;38,72;Netherlands;Elsevier BV;1959, 1981-ongoing;"Pharmacology (Q1); Virology (Q2)"
111;25786;Bioorganic and Medicinal Chemistry;journal;14643391, 09680896;1,062;Q1;142;668;2104;23871;5419;2081;2,56;35,74;United Kingdom;Elsevier Ltd.;1993-ongoing;"Drug Discovery (Q1); Pharmaceutical Science (Q1); Biochemistry (Q2); Clinical Biochemistry (Q2); Molecular Medicine (Q2); Organic Chemistry (Q2); Molecular Biology (Q3)"
112;29097;Cancer Chemotherapy and Pharmacology;journal;03445704;1,053;Q1;100;201;568;6213;1496;562;2,70;30,91;Germany;Springer Verlag;1978-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1); Cancer Research (Q2); Oncology (Q2)"
113;25219;Toxicology;journal;0300483X;1,053;Q1;143;301;901;12833;2705;880;3,04;42,63;Netherlands;Elsevier BV;1959, 1973-ongoing;Toxicology (Q1)
114;19034;Microbial Drug Resistance;journal;10766294;1,042;Q1;62;43;157;1347;293;156;1,69;31,33;United States;Mary Ann Liebert Inc.;1995-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Immunology (Q2); Microbiology (Q2); Microbiology (medical) (Q2)"
115;18073;NeuroToxicology;journal;0161813X;1,036;Q1;102;138;339;5434;974;320;3,11;39,38;Netherlands;Elsevier BV;1979-ongoing;"Toxicology (Q1); Neuroscience (miscellaneous) (Q2)"
116;20679;Current Opinion in Investigational Drugs;journal;14724472;1,033;Q1;71;106;428;6575;1132;392;3,06;62,03;United Kingdom;Current Drugs Ltd.;1994, 2000-2010;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
117;110174;Prostaglandins and Other Lipid Mediators;journal;10988823;1,017;Q1;67;73;160;3443;340;158;2,07;47,16;Netherlands;Elsevier BV;1996, 1998-ongoing;"Pharmacology (Q1); Biochemistry (Q2); Physiology (Q2); Cell Biology (Q3)"
118;21333;European Journal of Pharmacology;journal;00142999;1,002;Q2;167;723;2154;27515;5678;2124;2,44;38,06;Netherlands;Elsevier BV;1967-ongoing;Pharmacology (Q2)
119;17595;Journal of Biomolecular Screening;journal;10870571;0,998;Q1;69;100;255;2489;619;251;2,25;24,89;United States;Sage Science Press;1996-ongoing;"Drug Discovery (Q1); Analytical Chemistry (Q2); Biochemistry (Q2); Biotechnology (Q2); Molecular Medicine (Q2); Pharmacology (Q2)"
120;21169;Pharmacological Research;journal;10436618, 10961186;0,986;Q2;118;133;428;8027;1225;420;2,83;60,35;United States;Elsevier Inc.;1989-ongoing;Pharmacology (Q2)
121;20680;Current Opinion in Molecular Therapeutics;journal;14648431;0,985;Q1;60;76;240;4448;548;213;2,59;58,53;United Kingdom;Current Drugs Ltd.;1999-2010;"Drug Discovery (Q1); Molecular Medicine (Q2); Pharmacology (Q2); Genetics (Q3); Genetics (clinical) (Q3); Molecular Biology (Q3)"
122;21455;Progress in Medicinal Chemistry;book series;00796468;0,981;Q2;33;5;23;777;50;20;3,07;155,40;Netherlands;Elsevier BV;1961-1963, 1965, 1967, 1969-ongoing;"Molecular Medicine (Q2); Pharmacology (Q2)"
123;21841;Food Additives and Contaminants;journal;0265203X, 14645122;0,975;Q1;90;168;446;5247;1032;437;2,23;31,23;United Kingdom;Taylor & Francis;1984-2008;"Chemistry (miscellaneous) (Q1); Food Science (Q1); Health, Toxicology and Mutagenesis (Q1); Public Health, Environmental and Occupational Health (Q1); Toxicology (Q1)"
124;28727;Anti-Cancer Drugs;journal;09594973, 14735741;0,974;Q2;88;152;417;5735;1029;414;2,60;37,73;United States;Lippincott Williams & Wilkins Ltd.;1990-ongoing;"Pharmacology (medical) (Q1); Cancer Research (Q2); Oncology (Q2); Pharmacology (Q2)"
125;21167;Pharmacogenomics;journal;14622416;0,973;Q2;83;152;302;7381;942;273;3,32;48,56;United Kingdom;Ashley Publications Ltd.;2000-ongoing;"Molecular Medicine (Q2); Pharmacology (Q2); Genetics (Q3)"
126;22982;Journal of Cardiovascular Pharmacology and Therapeutics;journal;10742484;0,970;Q2;44;34;124;1317;213;112;1,97;38,74;United States;SAGE Publications;1996-ongoing;"Cardiology and Cardiovascular Medicine (Q1); Pharmacology (medical) (Q1); Pharmacology (Q2)"
127;14144;Experimental and Clinical Psychopharmacology;journal;10641297;0,964;Q2;82;52;126;2964;269;123;2,08;57,00;United States;American Psychological Association;1993-ongoing;"Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Pharmacology (Q2)"
128;130025;Current Drug Delivery;journal;15672018;0,959;Q1;54;35;129;2110;394;127;3,09;60,29;United Arab Emirates;Bentham Science Publishers;2004-ongoing;Pharmaceutical Science (Q1)
129;22378;Vascular Pharmacology;journal;15371891;0,959;Q2;86;96;231;3595;544;224;2,59;37,45;Netherlands;Elsevier BV;2002-ongoing;"Molecular Medicine (Q2); Pharmacology (Q2); Physiology (Q2)"
130;4700152612;Current Nanoscience;journal;15734137;0,958;Q1;37;39;35;2293;75;33;2,27;58,79;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Biomedical Engineering (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Bioengineering (Q2); Biotechnology (Q2); Nanoscience and Nanotechnology (Q2)"
131;24652;Chemico-Biological Interactions;journal;00092797;0,957;Q1;108;145;427;5787;1172;418;2,75;39,91;Netherlands;Elsevier BV;1969-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
132;23014;Journal of Drug Targeting;journal;10292330, 1061186X;0,957;Q1;80;77;215;2989;485;198;2,23;38,82;United Kingdom;Taylor & Francis;1986-1987, 1992-ongoing;Pharmaceutical Science (Q1)
133;20602;Clinical Neuropharmacology;journal;03625664;0,955;Q2;74;56;200;1415;542;185;2,73;25,27;United States;Lippincott Williams & Wilkins Ltd.;1982-ongoing;"Pharmacology (medical) (Q1); Neurology (clinical) (Q2); Pharmacology (Q2)"
134;19900193739;Nucleic Acid Therapeutics;journal;21593345, 21593337;0,953;Q2;61;38;91;1773;226;85;2,64;46,66;United States;Mary Ann Liebert Inc.;2011-ongoing;"Biochemistry (Q2); Drug Discovery (Q2); Molecular Medicine (Q2); Genetics (Q3); Molecular Biology (Q3)"
135;15581;Current Pharmaceutical Biotechnology;journal;13892010;0,951;Q1;73;47;167;4167;476;144;2,63;88,66;United Arab Emirates;Bentham Science Publishers;2000-ongoing;"Pharmaceutical Science (Q1); Biotechnology (Q2)"
136;25240;Toxicology Letters;journal;03784274;0,951;Q2;129;188;728;6816;2156;706;2,99;36,26;Netherlands;Elsevier BV;1977-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
137;21350;Expert Opinion on Emerging Drugs;journal;14728214, 17447623;0,950;Q2;43;45;111;4719;289;111;2,58;104,87;United Kingdom;Taylor & Francis;2000-ongoing;"Pharmacology (medical) (Q1); Pharmacology (Q2)"
138;25109;Inhalation Toxicology;journal;08958378, 10917691;0,950;Q2;77;122;296;4400;718;288;1,90;36,07;United Kingdom;Taylor & Francis;1989-ongoing;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q2)"
139;11700154735;Journal of Aerosol Medicine and Pulmonary Drug Delivery;journal;19412711;0,946;Q1;61;62;114;1283;332;110;3,10;20,69;United States;Mary Ann Liebert Inc.;2008-ongoing;"Pharmaceutical Science (Q1); Pharmacology (medical) (Q1); Pulmonary and Respiratory Medicine (Q1)"
140;4000148019;AAPS Journal;journal;15507416;0,940;Q1;96;40;228;1627;623;220;3,28;40,68;United States;Springer New York;1999-ongoing;Pharmaceutical Science (Q1)
141;20082;British Journal of Clinical Pharmacology;journal;13652125, 03065251;0,934;Q2;131;233;667;5489;1669;536;2,94;23,56;United Kingdom;Blackwell Publishing Inc.;1974-ongoing;"Pharmacology (medical) (Q1); Pharmacology (Q2)"
142;21331;European Journal of Pharmaceutical Sciences;journal;09280987;0,933;Q1;119;104;590;3140;1468;582;2,21;30,19;Netherlands;Elsevier BV;1993-ongoing;Pharmaceutical Science (Q1)
143;15300154846;Journal of Occupational Medicine and Toxicology;journal;17456673;0,911;Q2;33;14;27;469;43;27;1,59;33,50;United Kingdom;BioMed Central;2006-ongoing;"Public Health, Environmental and Occupational Health (Q1); Safety Research (Q1); Toxicology (Q2)"
144;23015;Journal of Ethnopharmacology;journal;03788741;0,905;Q2;170;428;1174;15453;3179;1154;2,53;36,11;Netherlands;Elsevier BV;1979-ongoing;"Drug Discovery (Q2); Pharmacology (Q2)"
145;25075;Ecotoxicology;journal;09639292, 15733017;0,899;Q2;81;56;204;3118;382;196;1,95;55,68;Netherlands;Kluwer Academic Publishers;1992-ongoing;"Management, Monitoring, Policy and Law (Q1); Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
146;16948;Chirality;journal;1520636X, 08990042;0,891;Q2;73;101;332;3445;664;325;2,27;34,11;United States;John Wiley & Sons Inc.;1989-ongoing;"Analytical Chemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Spectroscopy (Q2); Catalysis (Q3)"
147;13845;Bulletin of Mathematical Biology;journal;00928240, 15229602;0,885;Q2;78;111;240;3896;458;233;1,69;35,10;United States;Springer New York LLC;1973-ongoing;"Agricultural and Biological Sciences (miscellaneous) (Q1); Environmental Science (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Computational Theory and Mathematics (Q2); Mathematics (miscellaneous) (Q2); Neuroscience (miscellaneous) (Q2); Pharmacology (Q2); Immunology (Q3)"
148;18075;Neurotoxicology and Teratology;journal;08920362;0,884;Q2;89;65;238;3773;584;224;2,59;58,05;Netherlands;Elsevier BV;1987-ongoing;"Toxicology (Q2); Developmental Neuroscience (Q3); Cellular and Molecular Neuroscience (Q4)"
149;24786;Alcohol and Alcoholism;journal;07350414, 14643502;0,882;Q2;89;90;306;3417;709;291;2,31;37,97;United Kingdom;Oxford University Press;1965-ongoing;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q2); Toxicology (Q2)"
150;20473;Life Sciences;journal;00243205;0,880;Q1;150;472;1771;19182;4464;1758;2,34;40,64;Netherlands;Elsevier BV;1962-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2)"
151;25176;Regulatory Toxicology and Pharmacology;journal;02732300, 10960295;0,878;Q2;90;100;246;3961;580;224;2,37;39,61;United States;Elsevier Inc.;1981-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
152;24785;Alcohol;journal;07418329;0,867;Q2;74;46;223;2488;519;214;2,19;54,09;Netherlands;Elsevier BV;1984-ongoing;"Health (social science) (Q1); Medicine (miscellaneous) (Q1); Biochemistry (Q2); Neurology (Q2); Toxicology (Q2); Behavioral Neuroscience (Q3)"
153;4600151526;Cardiovascular and Hematological Disorders - Drug Targets;journal;1871529X;0,866;Q2;37;31;111;3034;283;102;2,75;97,87;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q1); Cardiology and Cardiovascular Medicine (Q2); Hematology (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
154;23382;Clinical and Experimental Pharmacology and Physiology;journal;14401681, 03051870;0,866;Q2;95;216;522;8625;1075;513;2,15;39,93;United Kingdom;Blackwell Publishing Inc.;1974-ongoing;"Pharmacology (Q2); Physiology (Q2); Physiology (medical) (Q2)"
155;18966;Mutagenesis;journal;02678357, 14643804;0,866;Q2;82;52;176;2531;437;169;2,62;48,67;United Kingdom;Oxford University Press;1986-ongoing;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Genetics (Q3); Genetics (clinical) (Q3)"
156;21687;American Journal of PharmacoGenomics;journal;11752203;0,858;Q2;36;0;75;0;211;74;2,75;0,00;United Kingdom;Adis International Ltd.;2001-2005;"Pharmacology (Q2); Genetics (Q3); Molecular Medicine (Q3)"
157;16319;IEEE Transactions on Nanobioscience;journal;15361241;0,853;Q1;55;48;105;1569;354;100;3,11;32,69;United States;Institute of Electrical and Electronics Engineers;2002-ongoing;"Computer Science Applications (Q1); Electrical and Electronic Engineering (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Bioengineering (Q2); Biomedical Engineering (Q2); Biotechnology (Q2); Nanoscience and Nanotechnology (Q2)"
158;22983;Journal of Clinical Pharmacology;journal;00912700;0,848;Q2;106;163;440;4568;1341;427;3,28;28,02;United States;Wiley-Blackwell;1961-1964, 1970-ongoing;"Pharmacology (medical) (Q1); Pharmacology (Q2)"
159;20427;Naunyn-Schmiedeberg's Archives of Pharmacology;journal;00281298;0,847;Q2;83;67;373;4330;788;361;2,16;64,63;Germany;Springer Verlag;1969-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
160;17464;European Journal of Medicinal Chemistry;journal;02235234;0,842;Q2;135;160;455;4891;1061;448;2,25;30,57;Netherlands;Elsevier BV;1974-ongoing;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2)"
161;21744;Planta Medica;journal;14390221, 00320943;0,839;Q1;103;236;753;5568;1584;728;1,92;23,59;Germany;Georg Thieme Verlag;1961, 1965-ongoing;"Complementary and Alternative Medicine (Q1); Pharmaceutical Science (Q1); Analytical Chemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
162;22432;International Immunopharmacology;journal;15675769;0,836;Q2;98;176;619;7329;1428;596;2,23;41,64;Netherlands;Elsevier BV;2001-ongoing;"Immunology and Allergy (Q2); Pharmacology (Q2); Immunology (Q3)"
163;22319;Toxicon;journal;00410101;0,828;Q2;116;220;694;9268;1650;672;2,30;42,13;United Kingdom;Elsevier Ltd.;1962-ongoing;Toxicology (Q2)
164;29953;Journal of Experimental Therapeutics and Oncology;journal;13594117;0,824;Q2;36;25;66;1100;140;66;2,26;44,00;United States;Old City Publishing Inc.;1996, 2002-ongoing;"Drug Discovery (Q2); Pharmacology (Q2); Cancer Research (Q3)"
165;20027;BMC Pharmacology;journal;14712210;0,821;Q2;38;15;64;542;144;63;1,94;36,13;United Kingdom;BioMed Central;2001-2012;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
166;9000153111;Comparative Biochemistry and Physiology, Part C;journal;15320456;0,820;Q2;99;142;357;8119;854;355;2,43;57,18;Netherlands;Elsevier BV;2000-ongoing;"Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Physiology (Q2); Toxicology (Q2); Biochemistry (Q3); Cell Biology (Q3)"
167;22299;Therapeutic Drug Monitoring;journal;15363694, 01634356;0,820;Q2;87;114;407;3447;1039;376;2,42;30,24;United States;Lippincott Williams & Wilkins Ltd.;1979-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
168;22981;Journal of Cardiovascular Pharmacology;journal;15334023, 01602446;0,813;Q2;91;137;705;5762;1335;698;2,16;42,06;United States;Lippincott Williams & Wilkins Ltd.;1979-ongoing;"Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2)"
169;4000150314;Chemical Biology and Drug Design;journal;17470277;0,810;-;71;114;312;3689;519;296;1,76;32,36;United Kingdom;Blackwell;2006-ongoing;"Biochemistry (Q3); Molecular Medicine (Q3)"
170;22552;Cardiovascular Drugs and Therapy;journal;15737241, 09203206;0,808;Q2;63;66;185;2362;329;158;2,26;35,79;Netherlands;Kluwer Academic Publishers;1987-ongoing;"Medicine (miscellaneous) (Q1); Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
171;23129;Journal of Veterinary Pharmacology and Therapeutics;journal;01407783, 13652885;0,805;Q2;54;87;215;2549;306;205;1,11;29,30;United Kingdom;Blackwell Publishing Inc.;1978-ongoing;"Veterinary (miscellaneous) (Q1); Pharmacology (Q2)"
172;25096;Food and Chemical Toxicology;journal;02786915;0,803;Q2;149;355;611;12349;1659;599;2,38;34,79;Netherlands;Elsevier BV;1982-ongoing;"Food Science (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q2)"
173;24074;Helvetica Chimica Acta;journal;0018019X, 15222675;0,802;Q2;79;219;798;6369;1233;789;1,57;29,08;United States;Wiley-Blackwell;1918-ongoing;"Drug Discovery (Q2); Inorganic Chemistry (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2); Biochemistry (Q3); Catalysis (Q3)"
174;22575;Cardiovascular Toxicology;journal;15307905;0,801;Q2;47;37;84;1413;186;84;1,80;38,19;United States;Humana Press, Inc.;2001-ongoing;"Cardiology and Cardiovascular Medicine (Q2); Toxicology (Q2); Molecular Biology (Q3)"
175;20783;Expert Review of Vaccines;journal;14760584;0,801;Q2;75;98;260;6944;516;236;2,26;70,86;United Kingdom;Taylor & Francis;2002-ongoing;"Drug Discovery (Q2); Pharmacology (Q2); Immunology (Q3); Molecular Medicine (Q3)"
176;19984;Assay and Drug Development Technologies;journal;1540658X;0,796;Q2;52;107;176;1707;339;167;1,82;15,95;United States;Mary Ann Liebert Inc.;2002-ongoing;"Drug Discovery (Q2); Molecular Medicine (Q3)"
177;23942;Biomedical Chromatography;journal;10990801, 02693879;0,788;Q2;58;177;411;3922;741;408;1,75;22,16;United States;John Wiley & Sons Inc.;1986-ongoing;"Medicine (miscellaneous) (Q1); Analytical Chemistry (Q2); Clinical Biochemistry (Q2); Drug Discovery (Q2); Pharmacology (Q2); Biochemistry (Q3); Molecular Biology (Q3)"
178;20051;BioDrugs;journal;11738804;0,787;Q2;60;39;107;2634;286;104;2,76;67,54;United Kingdom;Adis International Ltd.;1997-ongoing;"Medicine (miscellaneous) (Q1); Biotechnology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
179;20770;Drug Delivery;journal;10717544;0,787;Q1;52;67;144;1395;301;144;1,71;20,82;United Kingdom;Taylor & Francis;1993, 1995-ongoing;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1)"
180;23453;Combinatorial Chemistry and High Throughput Screening;journal;13862073;0,784;Q2;59;85;246;5133;612;225;2,55;60,39;United Arab Emirates;Bentham Science Publishers;1998-ongoing;"Computer Science Applications (Q1); Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Organic Chemistry (Q2)"
181;21246;International Journal of Immunopathology and Pharmacology;journal;03946320;0,783;Q2;45;111;302;2603;908;287;3,84;23,45;Italy;SAGE Publications Inc.;1989-ongoing;"Immunology and Allergy (Q2); Pharmacology (Q2); Immunology (Q3)"
182;24619;Journal of Computer-Aided Molecular Design;journal;15734951, 0920654X;0,779;Q2;89;46;180;1712;410;180;2,05;37,22;Netherlands;Kluwer Academic Publishers;1987-ongoing;"Computer Science Applications (Q2); Drug Discovery (Q2); Physical and Theoretical Chemistry (Q2)"
183;21326;European Journal of Clinical Pharmacology;journal;00316970, 14321041;0,777;Q2;99;171;492;4296;1158;442;2,59;25,12;Germany;Springer Verlag;1968-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
184;25093;Environmental Toxicology;journal;15227278, 15204081;0,762;Q2;69;63;235;2437;452;230;1,79;38,68;United States;John Wiley & Sons Inc.;1980, 1999-ongoing;"Management, Monitoring, Policy and Law (Q1); Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
185;29053;Molecular Diversity;journal;1573501X, 13811991;0,748;Q2;54;19;145;532;270;139;2,01;28,00;Netherlands;Kluwer Academic Publishers;1995-1998, 2000, 2003-ongoing;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Information Systems (Q2); Inorganic Chemistry (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2); Catalysis (Q3); Molecular Biology (Q3)"
186;25151;Journal of Toxicology and Environmental Health - Part A;journal;10872620, 15287394;0,747;Q2;80;207;421;8310;794;414;1,74;40,14;United Kingdom;Taylor & Francis;1996-ongoing;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
187;28620;Biomedicine and Pharmacotherapy;journal;07533322;0,744;Q2;78;106;384;4584;880;373;1,98;43,25;France;Elsevier Masson;1982-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
188;4700152856;Expert Opinion on Drug Metabolism and Toxicology;journal;17425255;0,743;Q2;72;68;119;6384;306;117;2,62;93,88;United Kingdom;Informa Healthcare;2005-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Toxicology (Q2)"
189;16836;BMC Chemical Biology;journal;14726769;0,740;Q2;19;2;8;91;15;8;1,50;45,50;United Kingdom;BioMed Central;2001-2012;"Drug Discovery (Q2); Molecular Medicine (Q3)"
190;28794;Cancer Biotherapy and Radiopharmaceuticals;journal;10849785;0,728;Q2;55;79;234;2276;406;220;1,80;28,81;United States;Mary Ann Liebert Inc.;1996-ongoing;"Medicine (miscellaneous) (Q1); Oncology (Q2); Pharmacology (Q2); Radiology, Nuclear Medicine and Imaging (Q2); Cancer Research (Q3)"
191;25224;Toxicology in Vitro;journal;08872333;0,723;Q2;96;209;409;7204;1017;405;2,48;34,47;Netherlands;Elsevier BV;1987-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
192;17067;Phytomedicine;journal;09447113;0,721;Q1;105;133;342;3212;740;330;2,10;24,15;Netherlands;Elsevier BV;1994-ongoing;"Complementary and Alternative Medicine (Q1); Pharmaceutical Science (Q1); Drug Discovery (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
193;16533;Phytochemical Analysis;journal;09580344, 10991565;0,719;Q2;63;56;203;1195;324;202;1,44;21,34;United States;John Wiley & Sons Inc.;1990-ongoing;"Complementary and Alternative Medicine (Q1); Food Science (Q1); Medicine (miscellaneous) (Q1); Analytical Chemistry (Q2); Drug Discovery (Q2); Plant Science (Q2); Biochemistry (Q3); Molecular Medicine (Q3)"
194;20064;Biological and Pharmaceutical Bulletin;journal;13475215, 09186158;0,718;Q1;104;417;1387;11839;2583;1372;1,80;28,39;Japan;Pharmaceutical Society of Japan;1993-ongoing;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Pharmacology (Q2)"
195;4400151415;Cardiovascular and Hematological Agents in Medicinal Chemistry;journal;18715257;0,716;Q2;36;35;100;3696;213;100;1,94;105,60;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q1); Cardiology and Cardiovascular Medicine (Q2); Hematology (Q2); Pharmacology (Q2)"
196;25214;Toxicologic Pathology;journal;15331601, 01926233;0,716;Q2;96;116;313;4806;747;295;2,42;41,43;United States;SAGE Publications;1972-ongoing;"Pathology and Forensic Medicine (Q2); Toxicology (Q2); Cell Biology (Q3); Molecular Biology (Q3)"
197;21353;Expert Opinion on Therapeutic Patents;journal;13543776;0,714;Q2;61;97;342;5221;452;331;1,36;53,82;United Kingdom;Taylor & Francis;1991-ongoing;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Pharmacology (Q2)"
198;20129;Cardiovascular Drug Reviews;journal;15273466, 08975957;0,713;Q2;45;24;70;1493;159;69;1,98;62,21;United States;Neva Press, Inc.;1988-2007;"Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2)"
199;23363;Canadian Journal of Physiology and Pharmacology;journal;00084212, 12057541;0,712;Q2;77;136;416;6114;654;408;1,57;44,96;Canada;NRC Research Press;1964-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Physiology (Q3); Physiology (medical) (Q3)"
200;16803;Antiviral Chemistry and Chemotherapy;journal;09563202;0,711;Q2;46;33;96;1299;181;94;1,79;39,36;United Kingdom;SAGE Publications Inc.;2017-ongoing, 1991-ongoing;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Pharmacology (Q2); Virology (Q3)"
201;4000149101;Nanomedicine: Nanotechnology, Biology, and Medicine;journal;15499634, 15499642;0,709;Q1;106;39;86;1298;239;75;3,19;33,28;Netherlands;Elsevier BV;2005-ongoing;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Bioengineering (Q2); Biomedical Engineering (Q2); Materials Science (miscellaneous) (Q2); Molecular Medicine (Q3); Nanoscience and Nanotechnology (Q3)"
202;15840;Journal of Antibiotics;journal;00218820;0,701;Q2;73;98;338;1888;437;303;1,23;19,27;United Kingdom;Nature Publishing Group;1953-ongoing;"Drug Discovery (Q2); Pharmacology (Q2)"
203;24578;Mathematical Medicine and Biology;journal;14778599;0,701;Q2;40;16;55;467;92;54;1,57;29,19;United Kingdom;Oxford University Press;1984-1995, 2003-ongoing;"Environmental Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Applied Mathematics (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Modeling and Simulation (Q2); Pharmacology (Q2); Immunology and Microbiology (miscellaneous)  (Q3); Neuroscience (miscellaneous) (Q3)"
204;25146;Journal of Pharmacological and Toxicological Methods;journal;10568719;0,697;Q2;64;82;185;2655;421;173;2,34;32,38;Netherlands;Elsevier BV;1992-2002, 2004-ongoing;"Pharmacology (Q2); Toxicology (Q2)"
205;14805;Steroids;journal;0039128X;0,696;Q2;95;109;361;4173;832;361;2,17;38,28;Netherlands;Elsevier BV;1963-ongoing;"Clinical Biochemistry (Q2); Endocrinology (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Biochemistry (Q3); Molecular Biology (Q3)"
206;22318;Toxicological Reviews;journal;11762551;0,689;Q2;42;0;68;0;191;61;2,97;0,00;United Kingdom;Adis International Ltd.;2003-2006;"Pharmacology (Q2); Toxicology (Q2)"
207;20026;BMC Clinical Pharmacology;journal;14726904;0,682;Q2;35;14;19;370;55;19;3,00;26,43;United Kingdom;BioMed Central;2001-2012;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
208;23412;Journal of AOAC International;journal;10603271;0,682;Q2;79;191;655;4601;1084;641;1,62;24,09;United States;AOAC International;1993-ongoing;"Agronomy and Crop Science (Q1); Food Science (Q1); Analytical Chemistry (Q2); Environmental Chemistry (Q2); Pharmacology (Q2)"
209;24604;Archives of Toxicology;journal;14320738, 03405761;0,681;Q2;96;80;285;2965;570;273;1,87;37,06;Germany;Springer Verlag;1972-ongoing;"Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
210;21865;Fundamental and Clinical Pharmacology;journal;07673981;0,679;Q2;64;92;213;3443;468;208;2,49;37,42;United Kingdom;Blackwell Publishing Inc.;1987-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
211;144956;Drug Metabolism and Pharmacokinetics;journal;13474367, 18800920;0,674;Q1;58;60;173;406;427;173;2,36;6,77;United Kingdom;Elsevier Limited;2004-ongoing;"Pharmaceutical Science (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
212;130063;Pharmacological Reports;journal;17341140, 22995684;0,673;Q2;71;122;349;4537;681;347;2,18;37,19;Netherlands;Elsevier BV;1998-2002, 2005-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
213;19403;Acta Pharmacologica Sinica;journal;16714083, 17457254;0,670;Q2;78;246;697;9225;1202;685;1,67;37,50;United States;Nature Publishing Group;1980-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
214;19900192900;Molecular Informatics;journal;18681751, 18681743;0,664;Q2;60;97;252;3918;537;238;2,18;40,39;Germany;Wiley - VCH Verlag GmbH & CO. KGaA;2010-ongoing;"Computer Science Applications (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Molecular Medicine (Q3); Structural Biology (Q3)"
215;29682;Receptors and Channels;journal;10606823;0,663;Q2;41;0;19;0;47;19;0,00;0,00;United Kingdom;Taylor & Francis;1993-2004;"Clinical Biochemistry (Q2); Pharmacology (Q2); Cell Biology (Q3); Endocrinology (Q3)"
216;20047;Basic and Clinical Pharmacology and Toxicology;journal;17427835;0,662;Q2;80;134;370;4519;751;359;1,99;33,72;United States;Wiley-Blackwell;2004-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Toxicology (Q2)"
217;21229;Drug News and Perspectives;journal;02140934;0,656;Q2;47;78;236;3455;374;235;1,57;44,29;Spain;J.R. Prous;1990-2010;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
218;24028;Reproductive Toxicology;journal;08906238;0,656;Q2;99;105;345;5493;741;312;2,24;52,31;Netherlands;Elsevier BV;1987-ongoing;Toxicology (Q2)
219;20570;Chemotherapy;journal;00093157, 14219794;0,648;Q2;49;70;209;1999;349;203;1,72;28,56;Switzerland;S. Karger AG;1963-ongoing;"Drug Discovery (Q2); Infectious Diseases (Q2); Medicine (miscellaneous) (Q2); Oncology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
220;4400151608;ChemMedChem;journal;18607187, 18607179;0,638;Q1;92;173;386;9078;663;381;1,81;52,47;Germany;Wiley - V C H Verlag GmbbH & Co.;2006-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Organic Chemistry (Q2); Molecular Medicine (Q3)"
221;20634;Journal of Texture Studies;journal;00224901;0,636;Q2;48;37;118;1132;138;113;1,12;30,59;United States;Wiley-Blackwell;1969-ongoing;"Food Science (Q1); Pharmaceutical Science (Q2)"
222;23039;Journal of Liposome Research;journal;08982104, 15322394;0,634;Q2;44;24;62;759;132;60;2,26;31,63;United States;Marcel Dekker Inc.;1988-1990, 1992-ongoing;Pharmaceutical Science (Q2)
223;23050;Journal of Microencapsulation;journal;02652048, 14645246;0,627;Q2;70;62;214;1569;263;212;1,22;25,31;United Kingdom;Taylor & Francis;1984-ongoing;"Bioengineering (Q2); Colloid and Surface Chemistry (Q2); Organic Chemistry (Q2); Pharmaceutical Science (Q2); Physical and Theoretical Chemistry (Q2)"
224;21100370879;Journal of managed care & specialty pharmacy;journal;23761032, 23760540;0,620;Q2;55;119;296;2878;326;205;1,59;24,18;United States;Academy of Managed Care Pharmacy (AMCP);2014-ongoing;"Pharmacy (Q1); Health Policy (Q2); Pharmaceutical Science (Q2)"
225;22410;Inflammation Research;journal;1420908X, 10233830;0,618;Q2;82;100;412;2766;582;404;1,49;27,66;Switzerland;Birkhauser Verlag;1995-ongoing;"Pharmacology (Q2); Immunology (Q3)"
226;15462;Biotechnology and Applied Biochemistry;journal;14708744, 08854513;0,617;Q2;62;66;201;2325;376;199;1,38;35,23;United States;Wiley-Blackwell;1986-ongoing;"Applied Microbiology and Biotechnology (Q2); Bioengineering (Q2); Biomedical Engineering (Q2); Biotechnology (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Process Chemistry and Technology (Q2); Molecular Medicine (Q3)"
227;21190;Drug Development and Industrial Pharmacy;journal;03639045, 15205762;0,616;Q2;78;137;341;3620;461;336;1,19;26,42;United States;Marcel Dekker Inc.;1974, 1976-ongoing;"Drug Discovery (Q2); Pharmacology (Q2); Organic Chemistry (Q3)"
228;27087;American Journal of Therapeutics;journal;10752765, 15363686;0,610;Q2;55;96;263;3410;464;242;1,87;35,52;United States;Lippincott Williams & Wilkins Ltd.;1960-1961, 1996-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
229;4000148406;Clinical Toxicology;journal;15563650;0,609;Q2;85;140;284;3516;493;230;1,90;25,11;United Kingdom;Taylor & Francis;1968-1998, 2005-ongoing;"Medicine (miscellaneous) (Q2); Toxicology (Q2)"
230;25898;Journal of Peptide Science;journal;10752617, 10991387;0,609;Q2;60;108;285;3775;475;275;1,72;34,95;United States;John Wiley & Sons Inc.;1995-ongoing;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Biochemistry (Q3); Molecular Medicine (Q3); Organic Chemistry (Q3); Structural Biology (Q3); Molecular Biology (Q4)"
231;19374;AAPS PharmSciTech;journal;15221059, 15309932;0,606;Q2;79;105;253;2643;383;238;1,65;25,17;United States;American Association of Pharmaceutical Scientists;2000-ongoing;"Agronomy and Crop Science (Q2); Aquatic Science (Q2); Drug Discovery (Q2); Ecology (Q2); Ecology, Evolution, Behavior and Systematics (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
232;21099;Pharmaceutical Development and Technology;journal;10837450, 10979867;0,605;Q2;50;62;152;1769;186;149;1,04;28,53;United States;Marcel Dekker Inc.;1996-ongoing;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
233;23479;Journal of Physiology and Pharmacology;journal;08675910, 18991505;0,600;Q2;70;137;438;4122;632;435;1,34;30,09;Poland;Polish Physiological Society;1991-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Physiology (Q3)"
234;25864;Heterocycles;journal;03855414;0,599;Q2;61;411;1090;12315;1175;1078;1,05;29,96;Netherlands;Elsevier BV;1983, 1985-ongoing;"Analytical Chemistry (Q2); Pharmacology (Q2); Organic Chemistry (Q3)"
235;25126;Journal of Applied Toxicology;journal;10991263, 0260437X;0,599;Q2;76;78;214;3151;455;206;2,10;40,40;United States;John Wiley & Sons Inc.;1981-ongoing;Toxicology (Q2)
236;23081;Journal of Pharmacokinetics and Pharmacodynamics;journal;15738744, 1567567X;0,593;Q2;54;39;86;1256;146;82;1,87;32,21;United States;Kluwer Academic/Plenum Publishers;1996-1999, 2001-ongoing;Pharmacology (Q2)
237;29550;Journal of Biochemical and Molecular Toxicology;journal;10956670, 10990461;0,589;Q3;53;50;133;1705;212;130;1,55;34,10;United States;John Wiley & Sons Inc.;1998-ongoing;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Biochemistry (Q3); Molecular Medicine (Q3); Toxicology (Q3); Molecular Biology (Q4)"
238;4400151410;Human Vaccines;journal;15548600, 15548619;0,588;Q1;49;53;73;1592;116;70;1,66;30,04;United States;Landes Bioscience;2005-2011;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Immunology (Q3)"
239;23102;Journal of Pharmacy and Pharmacology;journal;00223573;0,587;Q2;107;199;606;7984;1095;601;1,81;40,12;United States;Wiley-Blackwell;1949-ongoing;"Pharmaceutical Science (Q2); Pharmacology (Q2)"
240;16067;Reading Teacher;journal;00340561;0,581;Q2;44;72;212;1585;88;211;0,31;22,01;United States;Wiley-Blackwell;1995-ongoing;"Language and Linguistics (Q1); Linguistics and Language (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
241;16573;Phytotherapy Research;journal;10991573, 0951418X;0,578;Q2;112;234;627;6591;1139;622;1,70;28,17;United States;John Wiley & Sons Inc.;1987-ongoing;Pharmacology (Q2)
242;21352;Expert Opinion on Pharmacotherapy;journal;14656566;0,577;Q2;69;264;713;19049;1376;684;2,03;72,16;United Kingdom;Taylor & Francis;1999-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
243;4700152603;Medicinal Chemistry;journal;15734064;0,576;Q2;39;73;120;2773;191;120;1,59;37,99;United Arab Emirates;Bentham Science Publishers;2005-ongoing;Drug Discovery (Q2)
244;34645;Skin Pharmacology and Physiology;journal;16605527, 16605535;0,576;Q2;68;35;136;1124;289;128;2,13;32,11;Switzerland;S. Karger AG;2004-ongoing;"Dermatology (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Physiology (Q3)"
245;23089;Journal of Pharmacy and Pharmaceutical Sciences;journal;14821826;0,575;Q2;69;55;149;1622;316;147;1,80;29,49;Canada;Canadian Society for Pharmaceutical Sciences;1998-ongoing;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (Q2)"
246;24626;Cell Biology and Toxicology;journal;15736822, 07422091;0,574;Q3;56;45;93;1909;161;93;1,81;42,42;Netherlands;Kluwer Academic Publishers;1984-ongoing;"Health, Toxicology and Mutagenesis (Q2); Cell Biology (Q3); Toxicology (Q3)"
247;130047;Current Drug Discovery Technologies;journal;15701638;0,557;Q2;38;23;69;1387;127;67;1,47;60,30;United Arab Emirates;Bentham Science Publishers;2004-ongoing;Drug Discovery (Q2)
248;23035;Journal of Biopharmaceutical Statistics;journal;10543406, 15205711;0,555;Q2;43;69;207;1234;184;189;0,73;17,88;United States;Marcel Dekker Inc.;1991-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2); Statistics and Probability (Q3)"
249;14822;Xenobiotica;journal;00498254, 13665928;0,555;Q2;75;85;215;3369;413;213;1,99;39,64;United Kingdom;Taylor & Francis;1971-ongoing;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Biochemistry (Q3); Toxicology (Q3)"
250;21207;Drug Discovery Today: Technologies;journal;17406749;0,553;Q2;41;21;177;331;284;166;1,31;15,76;Netherlands;Elsevier BV;2004-ongoing;"Drug Discovery (Q2); Biotechnology (Q3); Molecular Medicine (Q3)"
251;22769;Chemical and Pharmaceutical Bulletin;journal;00092363, 13475223;0,546;Q2;84;330;1069;7792;1387;1064;1,23;23,61;Japan;Pharmaceutical Society of Japan;1958, 1962-ongoing;"Chemistry (miscellaneous) (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2)"
252;23007;Journal of Clinical Pharmacy and Therapeutics;journal;13652710, 02694727;0,544;Q2;65;72;250;2168;353;228;1,49;30,11;United Kingdom;Blackwell Publishing Inc.;1976-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
253;21256;Drugs of Today;journal;16993993, 16994019;0,541;Q3;46;60;235;4019;452;231;2,03;66,98;Spain;Prous Science;1968, 1978-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
254;18077;Fitoterapia;journal;0367326X;0,540;Q2;90;147;432;2263;662;428;1,30;15,39;Netherlands;Elsevier BV;1948-1949, 1961, 1972-ongoing;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
255;17605;Journal of Enzyme Inhibition and Medicinal Chemistry;journal;14756374, 14756366;0,534;Q3;61;80;260;2424;415;256;1,41;30,30;United Kingdom;Taylor & Francis;1985-ongoing;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3); Pharmacology (Q3)"
256;19443;American Journal of Health-System Pharmacy;journal;10792082;0,526;Q3;87;444;1233;7135;1241;753;1,50;16,07;United States;American Society of Health-System Pharmacists;1995-ongoing;"Health Policy (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
257;14487;Journal of Ocular Pharmacology and Therapeutics;journal;10807683;0,518;Q3;53;68;181;2035;228;175;1,32;29,93;United States;Mary Ann Liebert Inc.;1995-ongoing;"Ophthalmology (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
258;25305;SAR and QSAR in Environmental Research;journal;1029046X, 1062936X;0,513;Q3;42;47;112;1882;214;112;1,70;40,04;United Kingdom;Taylor & Francis;1993-ongoing;"Medicine (miscellaneous) (Q2); Bioengineering (Q3); Drug Discovery (Q3); Molecular Medicine (Q3)"
259;19447;Journal of the American Pharmacists Association : JAPhA;journal;15443191, 15443450;0,504;Q3;58;112;337;1318;302;309;0,94;11,77;United States;Elsevier Inc.;2003-ongoing;"Pharmacology (nursing) (Q1); Pharmacy (Q1); Pharmacology (Q3)"
260;22434;International Journal of Clinical Pharmacology and Therapeutics;journal;09461965;0,503;Q3;62;71;303;1586;442;284;1,33;22,34;Germany;Dustri-Verlag Dr. Karl Feistle;1994-ongoing;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
261;144790;Marine Drugs;journal;16603397;0,501;Q3;84;15;35;505;42;34;1,14;33,67;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);2005-ongoing;Drug Discovery (Q3)
262;28636;Birth Defects Research Part B - Developmental and Reproductive Toxicology;journal;15429733, 15429741;0,499;Q3;54;30;100;1905;151;94;1,56;63,50;United States;John Wiley & Sons Inc.;2003-ongoing;"Embryology (Q2); Developmental Biology (Q3); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
263;5800173385;Recent Patents on Anti-Cancer Drug Discovery;journal;15748928;0,499;Q3;36;20;27;2470;31;27;1,15;123,50;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Cancer Research (Q3); Drug Discovery (Q3); Oncology (Q3)"
264;21124;Pharmaceutical Statistics;journal;15391612, 15391604;0,493;Q3;33;28;98;628;54;81;0,68;22,43;United States;John Wiley & Sons Inc.;2004-ongoing;"Pharmacology (medical) (Q2); Pharmacology (Q3); Statistics and Probability (Q3)"
265;14990;Current Neuropharmacology;journal;1570159X;0,489;Q3;58;27;83;3761;77;79;0,88;139,30;United Arab Emirates;Bentham Science Publishers;2004-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Psychiatry and Mental Health (Q2); Neurology (Q3); Neurology (clinical) (Q3); Pharmacology (Q3)"
266;19956;Archiv der Pharmazie;journal;15214184, 03656233;0,483;Q2;54;77;228;2112;269;225;1,21;27,43;United Kingdom;John Wiley & Sons Ltd.;1959-1965, 1972-ongoing;"Pharmaceutical Science (Q2); Drug Discovery (Q3)"
267;110172;Progress in Drug Research;book series;0071786X;0,481;Q1;38;13;23;993;31;21;1,48;76,38;Switzerland;Birkhauser Verlag;1959-1966, 1968-1969, 1972-2003, 2005, 2007-2008, 2011, 2014-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Molecular Medicine (Q3)"
268;24043;Journal of Labelled Compounds and Radiopharmaceuticals;journal;03624803, 10991344;0,479;Q3;41;188;320;2228;305;314;0,96;11,85;United States;John Wiley & Sons Inc.;1976-ongoing;"Radiology, Nuclear Medicine and Imaging (Q2); Analytical Chemistry (Q3); Biochemistry (Q3); Drug Discovery (Q3); Organic Chemistry (Q3); Spectroscopy (Q3)"
269;24640;Journal of Liquid Chromatography and Related Technologies;journal;1520572X, 10826076;0,474;Q2;46;208;642;5391;607;636;1,00;25,92;United States;Marcel Dekker Inc.;1996-ongoing;"Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Biochemistry (Q3); Clinical Biochemistry (Q3)"
270;28675;Brazilian Journal of Medical and Biological Research;journal;0100879X;0,473;Q1;79;183;658;5384;891;653;1,31;29,42;Brazil;Associacao Brasileira de Divulgacao Cientifica;1973-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Biochemistry (Q3); Biophysics (Q3); Immunology (Q3); Neuroscience (miscellaneous) (Q3); Physiology (Q3); Cell Biology (Q4)"
271;20066;Biopharmaceutics and Drug Disposition;journal;1099081X, 01422782;0,468;Q2;54;44;139;1108;172;139;1,11;25,18;United States;John Wiley & Sons Inc.;1979-ongoing;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
272;25095;Environmental Toxicology and Pharmacology;journal;13826689;0,466;Q3;72;99;354;3546;471;350;1,38;35,82;Netherlands;Elsevier BV;1996-ongoing;"Medicine (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Toxicology (Q3)"
273;25129;Journal of Environmental Pathology, Toxicology and Oncology;journal;07318898;0,461;Q3;43;24;100;846;181;98;1,81;35,25;United States;Begell House;1984-1990, 1992-ongoing;"Medicine (miscellaneous) (Q2); Pathology and Forensic Medicine (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
274;21100218041;Anti-Infective Agents;journal;22113533, 22113525;0,457;Q3;21;23;75;2257;75;69;0,89;98,13;United Arab Emirates;Bentham Science Publishers;2012-ongoing;"Infectious Diseases (Q3); Pharmacology (Q3)"
275;18800156720;Dissolution Technologies;journal;1521298X;0,457;Q2;28;22;75;222;30;31;0,78;10,09;United States;Dissolution Technologies, Inc.;2008-ongoing;Pharmaceutical Science (Q2)
276;20580;Journal of Food Biochemistry;journal;01458884;0,457;Q3;40;41;126;1397;118;124;0,93;34,07;United States;Wiley-Blackwell;1977-ongoing;"Food Science (Q2); Biophysics (Q3); Pharmacology (Q3); Cell Biology (Q4)"
277;13248;Experimental and Toxicologic Pathology;journal;09402993;0,453;Q3;58;61;161;1940;267;160;1,65;31,80;Netherlands;Elsevier BV;1992-ongoing;"Medicine (miscellaneous) (Q2); Pathology and Forensic Medicine (Q3); Toxicology (Q3); Cell Biology (Q4)"
278;145580;International Journal of Peptide Research and Therapeutics;journal;15733149, 15733904;0,453;Q3;30;51;72;1710;70;70;1,00;33,53;Germany;Springer Verlag;1996-2002, 2005-ongoing;"Analytical Chemistry (Q3); Biochemistry (Q3); Bioengineering (Q3); Drug Discovery (Q3); Molecular Medicine (Q3)"
279;4700152848;PPAR Research;journal;16874757, 16874765;0,450;Q3;40;41;12;2838;13;10;1,30;69,22;Egypt;Hindawi Publishing Corporation;2006-ongoing;"Pharmacology (medical) (Q2); Drug Discovery (Q3)"
280;4700152426;Current Pharmaceutical Analysis;journal;15734129;0,435;Q2;22;28;32;2492;28;32;0,88;89,00;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Pharmaceutical Science (Q2); Biochemistry (Q3); Biophysics (Q3); Molecular Medicine (Q3)"
281;21273;Journal of Immune Based Therapies and Vaccines;journal;14768518;0,435;Q3;18;12;23;365;27;23;0,79;30,42;United Kingdom;BioMed Central;2003-2011;"Immunology (Q3); Pharmacology (Q3)"
282;27210;In Vivo;journal;0258851X;0,432;Q3;54;140;364;4518;500;359;1,37;32,27;Greece;International Institute of Anticancer Research;1987-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
283;21211;Pharmacy Education;journal;14772701, 15602214;0,426;Q2;15;48;93;805;57;92;0,48;16,77;United Kingdom;Taylor & Francis;1973-1978, 2002-ongoing;"Pharmacy (Q1); Education (Q2); Pharmaceutical Science (Q2)"
284;29947;Journal of Chemotherapy;journal;1120009X;0,419;Q3;45;131;429;2993;471;396;1,08;22,85;United Kingdom;Maney Publishing;1989-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Infectious Diseases (Q3); Oncology (Q3); Pharmacology (Q3)"
285;25106;Human and Experimental Toxicology;journal;09603271;0,408;Q3;71;124;258;4491;375;243;1,35;36,22;United States;SAGE Publications;1981-ongoing;"Medicine (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
286;21194;Pharmacology;journal;00317012, 14230313;0,406;Q3;54;70;241;2804;308;240;1,18;40,06;Switzerland;S. Karger AG;1968-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
287;19398;Acta Pharmaceutica;journal;13300075;0,404;Q2;49;24;113;561;162;111;1,33;23,38;Croatia;Hrvatsko Farmaceutsko Drustvo/Croatian Pharmaceutical Society;1992-ongoing;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (Q3)"
288;13671;Biologicals;journal;10958320, 10451056;0,404;Q3;51;55;126;1341;155;116;1,18;24,38;United States;Elsevier Inc.;1990-ongoing;"Medicine (miscellaneous) (Q2); Applied Microbiology and Biotechnology (Q3); Bioengineering (Q3); Biotechnology (Q3); Immunology and Microbiology (miscellaneous)  (Q3); Pharmacology (Q3)"
289;26370;Molecules;journal;14203049;0,404;Q2;116;190;372;6394;361;356;0,85;33,65;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);1996-ongoing;"Chemistry (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Drug Discovery (Q3); Molecular Medicine (Q3); Organic Chemistry (Q3); Physical and Theoretical Chemistry (Q3)"
290;5800173402;Recent Patents on CNS Drug Discovery;journal;15748898;0,398;Q3;29;22;25;2775;26;25;1,04;126,14;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Pharmacology (medical) (Q2); Psychiatry and Mental Health (Q2); Drug Discovery (Q3)"
291;4200151509;Molecular Diagnosis and Therapy;journal;11771062;0,396;Q3;34;42;43;2187;68;41;1,66;52,07;United Kingdom;Adis International Ltd.;2006-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q3); Genetics (Q4); Molecular Medicine (Q4)"
292;19958;Archives of Pharmacal Research;journal;02536269;0,395;Q3;75;204;602;5374;666;601;1,08;26,34;South Korea;Pharmaceutical Society of Korea;1978-ongoing;"Drug Discovery (Q3); Organic Chemistry (Q3); Molecular Medicine (Q4)"
293;5800173383;Current Clinical Pharmacology;journal;15748847;0,389;Q1;33;13;27;1657;15;27;0,56;127,46;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2)"
294;25149;Journal of Toxicological Sciences;journal;18803989, 03881350;0,387;Q3;44;40;109;1027;120;108;1,12;25,68;Japan;Japanese Society of Toxicological Sciences;1976-ongoing;"Medicine (miscellaneous) (Q2); Toxicology (Q3)"
295;22411;Inflammopharmacology;journal;09254692, 15685608;0,385;Q3;45;53;128;1647;135;122;1,20;31,08;Switzerland;Birkhauser Verlag;1991-ongoing;"Pharmacology (medical) (Q2); Immunology (Q3); Pharmacology (Q3)"
296;21264;Drugs in R and D;journal;11745886;0,381;Q3;39;42;146;1804;187;146;1,56;42,95;United Kingdom;Adis International Ltd.;1999, 2002-2008, 2010-ongoing;Pharmacology (Q3)
297;22204;Journal of Drug Delivery Science and Technology;journal;17732247;0,380;Q2;38;66;194;1957;149;192;0,77;29,65;France;Editions de Sante;2004-ongoing;Pharmaceutical Science (Q2)
298;21262;Drugs under Experimental and Clinical Research;journal;03786501;0,379;Q3;37;0;66;0;105;66;1,33;0,00;Switzerland;Bioscience Ediprint Inc.;1980-2005;"Pharmacology (medical) (Q2); Drug Discovery (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
299;26766;ATLA Alternatives to Laboratory Animals;journal;02611929;0,375;Q3;55;87;343;2446;365;313;2,10;28,11;United Kingdom;Fund for the Replacement of Animals in Medical Experiments;1982, 1985-1986, 1988-1989, 1994-ongoing;"Medical Laboratory Technology (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q3)"
300;19700182275;International Journal of Clinical Pharmacy;journal;22107711, 22107703;0,373;Q2;52;79;218;1743;190;193;0,85;22,06;Germany;Springer Verlag;2010-ongoing;"Pharmacy (Q1); Pharmaceutical Science (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3); Toxicology (Q3)"
301;20766;Drug and Chemical Toxicology;journal;01480545, 15256014;0,367;Q3;38;31;95;1097;109;93;1,00;35,39;United States;Marcel Dekker Inc.;1977-ongoing;"Chemical Health and Safety (Q1); Medicine (miscellaneous) (Q2); Public Health, Environmental and Occupational Health (Q2); Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Toxicology (Q3)"
302;21208;Drug Discovery Today: Therapeutic Strategies;journal;17406773;0,366;Q3;26;42;213;1785;164;200;0,65;42,50;Netherlands;Elsevier BV;2004-2014;"Drug Discovery (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
303;29634;Journal of Negative Results in BioMedicine;journal;14775751;0,366;Q2;19;9;36;259;46;36;1,34;28,78;United Kingdom;BioMed Central;2002-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)"
304;21192;Drug Development Research;journal;02724391, 10982299;0,361;Q3;54;52;262;2655;263;253;1,03;51,06;United States;John Wiley & Sons Inc.;1981-ongoing;Drug Discovery (Q3)
305;19441;American Journal of Drug Delivery;journal;11759038;0,358;Q3;19;0;70;0;61;63;0,88;0,00;United Kingdom;Adis International Ltd.;2004-2006;Pharmacology (Q3)
306;24624;Bulletin of Environmental Contamination and Toxicology;journal;00074861, 14320800;0,357;Q3;63;251;943;4619;570;936;0,54;18,40;Germany;Springer Verlag;1966-ongoing;"Medicine (miscellaneous) (Q2); Pollution (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
307;22980;Journal of Basic and Clinical Physiology and Pharmacology;journal;21910286, 07926855;0,346;Q3;30;21;58;522;57;58;1,13;24,86;Germany;Walter de Gruyter GmbH;1985-1988, 1990-ongoing;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3); Pharmacology (Q3); Physiology (Q4)"
308;23009;Journal of Clinical Research;journal;13695207;0,345;Q3;11;1;7;16;13;7;1,17;16,00;United Kingdom;Brookwood Medical Publications Ltd;1998-2009;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
309;15340;Developments in Biologicals;book series;14246074;0,343;Q3;35;90;295;1176;278;295;1,11;13,07;Switzerland;S. Karger AG;2000-2008, 2010-2013;"Immunology (Q3); Pharmacology (Q3); Biomaterials (Q4)"
310;19700180781;Strategies and Tactics in Organic Synthesis;book series;18746004;0,342;Q3;8;0;49;0;16;42;0,14;0,00;United States;Elsevier Inc.;2004-2005, 2008, 2012-ongoing;"Drug Discovery (Q3); Organic Chemistry (Q3)"
311;25111;International Journal of Toxicology;journal;10915818, 1092874X;0,341;Q3;51;60;177;3122;206;162;1,31;52,03;United States;SAGE Publications;1982-ongoing;Toxicology (Q3)
312;21100241807;Artificial Cells, Nanomedicine and Biotechnology;journal;2169141X, 21691401;0,340;Q2;35;52;126;1196;122;123;1,09;23,00;United States;Informa Healthcare;2013-ongoing;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Biomedical Engineering (Q3); Biotechnology (Q3)"
313;22372;Immunopharmacology and Immunotoxicology;journal;15322513, 08923973;0,340;Q3;42;46;162;1412;156;160;1,02;30,70;United States;Marcel Dekker Inc.;1978-ongoing;"Medicine (miscellaneous) (Q2); Immunology (Q3); Immunology and Allergy (Q3); Pharmacology (Q3); Toxicology (Q3)"
314;19927;Methods and Findings in Experimental and Clinical Pharmacology;journal;03790355;0,336;Q3;47;75;215;4091;234;214;1,00;54,55;Spain;Prous Science;1979-2010;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
315;21717;Die Pharmazie;journal;00317144;0,335;Q2;56;200;652;4405;590;646;0,90;22,03;Germany;Govi Verlag Pharmazeutischer Verlag GmbH;1947-ongoing;Pharmaceutical Science (Q2)
316;4900153304;Archives of Environmental and Occupational Health;journal;19338244;0,330;Q3;58;32;191;974;122;174;0,32;30,44;United States;Heldref Publications;2005-ongoing;"Environmental Science (miscellaneous) (Q2); Public Health, Environmental and Occupational Health (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
317;20545;PDA Journal of Pharmaceutical Science and Technology;journal;10797440;0,325;Q2;33;47;117;867;68;98;0,75;18,45;United States;Parenteral Drug Association Inc;1994-ongoing;Pharmaceutical Science (Q2)
318;19427;Advances in Pharmacology;book series;10543589;0,320;Q3;68;14;85;2270;55;78;0,85;162,14;United States;Elsevier Inc.;1962-1964, 1966-1973, 1975, 1977-1982, 1984, 1990-2000, 2004-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
319;34545;Journal of Asian Natural Products Research;journal;10286020, 14772213;0,317;Q2;35;108;235;1189;149;234;0,62;11,01;United Kingdom;Taylor & Francis;1998-ongoing;"Complementary and Alternative Medicine (Q1); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Drug Discovery (Q3); Pharmacology (Q3); Molecular Medicine (Q4); Organic Chemistry (Q4)"
320;23348;Journal of Environmental Biology;journal;23940379, 02548704;0,317;Q3;40;154;336;4118;201;334;0,59;26,74;India;Academy of Environmental Biology;1988-ongoing;"Environmental Engineering (Q3); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
321;4700152872;Journal of NeuroImmune Pharmacology;journal;15571890, 15571904;0,313;Q3;64;47;40;2177;31;38;0,82;46,32;Germany;Springer Verlag;2006-ongoing;"Immunology (Q3); Immunology and Allergy (Q3); Neuroscience (miscellaneous) (Q3); Pharmacology (Q3)"
322;59665;Chinese Journal of Natural Medicines;journal;18755364, 20956975;0,303;Q3;27;103;278;1483;131;277;0,38;14,40;China;China Pharmaceutical University;2004-ongoing;"Complementary and Alternative Medicine (Q2); Medicine (miscellaneous) (Q2); Drug Discovery (Q3)"
323;22881;Yao xue xue bao = Acta pharmaceutica Sinica;journal;05134870;0,303;Q2;29;224;668;3574;371;668;0,55;15,96;China;Nongton Jie;1960, 1962-1966, 1979-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Molecular Medicine (Q4)"
324;24111;Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry;journal;03764699;0,300;Q2;43;183;803;4144;347;797;0,37;22,64;India;Scientific Publishers;1970, 1973-1978, 1981, 1989-1991, 1996-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Organic Chemistry (Q4)"
325;25144;Journal of Health Science;journal;13475207, 13449702;0,298;Q3;42;118;343;2876;229;343;0,70;24,37;Kenya;African Forum for Health Sciences;1999-2011;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
326;23489;Chemical Speciation and Bioavailability;journal;09542299;0,296;Q3;25;19;48;638;39;48;0,80;33,58;United Kingdom;Taylor & Francis;1989-ongoing;"Chemical Health and Safety (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
327;20083;British Journal of Clinical Pharmacology, Supplement;journal;02643774;0,294;Q2;30;0;7;0;21;7;0,00;0,00;United Kingdom;Blackwell Publishing Inc.;1998, 2000-2004;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
328;19446;American Pharmaceutical Review;journal;10998012;0,290;Q2;20;116;294;1850;154;279;0,58;15,95;United States;Russell Publishing LLC;2002-ongoing;Pharmaceutical Science (Q2)
329;6800153101;Expert Opinion on Drug Discovery;journal;1746045X, 17460441;0,289;Q3;50;131;65;10146;58;65;0,89;77,45;United Kingdom;Informa Healthcare;2006-ongoing;Drug Discovery (Q3)
330;22392;Indian Journal of Pharmaceutical Sciences;journal;0250474X, 19983743;0,287;Q2;50;177;550;3144;221;543;0,39;17,76;India;Medknow Publications;1978-ongoing;Pharmaceutical Science (Q2)
331;22435;International Journal of Clinical Pharmacology Research;journal;02511649;0,284;Q2;29;0;42;0;51;42;1,16;0,00;Switzerland;Bioscience Ediprint Inc.;1981-2005;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
332;22456;International Journal of Pharmacy Practice;journal;09617671;0,284;Q2;32;39;107;959;57;101;0,61;24,59;United Kingdom;Wiley-Blackwell;1991-ongoing;"Pharmacy (Q1); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Health Policy (Q3); Public Health, Environmental and Occupational Health (Q3)"
333;22375;Indian Drugs;journal;0019462X;0,283;Q2;30;181;414;2741;110;414;0,22;15,14;India;Scientific Publishers;1989-ongoing;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Pharmacology (Q3)"
334;7700153108;International journal of nanomedicine;journal;11782013, 11769114;0,282;Q3;100;47;58;2505;33;54;0,61;53,30;New Zealand;Dove Medical Press Ltd;2006-ongoing;"Medicine (miscellaneous) (Q2); Bioengineering (Q3); Biophysics (Q3); Drug Discovery (Q3); Biomaterials (Q4); Nanoscience and Nanotechnology (Q4); Organic Chemistry (Q4)"
335;25223;Toxicology and Industrial Health;journal;07482337, 14770393;0,282;Q3;52;55;96;2542;106;95;1,06;46,22;United States;SAGE Publications;1985-ongoing;"Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3); Health, Toxicology and Mutagenesis (Q4)"
336;21100470510;Drug Research;journal;21949379, 21949387;0,281;Q3;56;122;361;2272;262;355;0,73;18,62;Germany;Thieme;1972, 2013-ongoing;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3)"
337;73430;Pharmaceutical Technology;journal;15432521;0,281;Q2;35;195;576;753;131;381;0,29;3,86;United States;UBM Medica Periodical Publication;1979-1985, 1987, 1996-ongoing;"Pharmaceutical Science (Q2); Biophysics (Q3)"
338;21265;Drugs of the Future;journal;03778282;0,278;Q3;40;113;1345;6144;224;348;0,66;54,37;Spain;Prous Science;1978-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
339;20578;Journal of Food and Drug Analysis;journal;10219498;0,272;Q3;41;64;186;1970;101;174;0,56;30,78;Taiwan;Elsevier Taiwan LLC;1994-ongoing;"Food Science (Q3); Pharmacology (Q3)"
340;19444;American Journal of Pharmaceutical Education;journal;15536467, 00029459;0,268;Q2;52;132;362;1806;188;345;0,51;13,68;United States;American Association of Colleges of Pharmacy;1947-1948, 1973-1989, 1991, 1996-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Education (Q3)"
341;37697;Autonomic and Autacoid Pharmacology;journal;14748665;0,266;Q3;30;25;97;825;58;96;0,57;33,00;United Kingdom;Blackwell Publishing Inc.;2002-ongoing;Pharmacology (Q3)
342;25253;Blutalkohol;journal;00065250;0,266;Q3;13;23;94;381;22;85;0,25;16,57;Germany;Springer Verlag;1974-2017 (cancelled);"Medicine (miscellaneous) (Q2); Toxicology (Q3)"
343;63982;Journal of Cannabis Therapeutics;journal;15299775, 15299783;0,265;Q3;14;0;4;0;5;3;0,00;0,00;United States;Haworth Integrative Healing Press;2002-2004;Pharmacology (Q3)
344;130038;Letters in Drug Design and Discovery;journal;15701808;0,261;Q2;28;98;198;3054;101;196;0,52;31,16;United Arab Emirates;Bentham Science Publishers;2005-ongoing;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Molecular Medicine (Q4)"
345;145524;Drug Discovery Today: Disease Mechanisms;journal;17406765;0,257;Q3;22;42;223;2084;104;202;0,45;49,62;Netherlands;Elsevier BV;2004-2014;"Drug Discovery (Q3); Molecular Medicine (Q4)"
346;130072;International Journal of Medicinal Mushrooms;journal;15219437;0,256;Q3;25;22;75;633;26;75;0,35;28,77;United States;Begell House;2005-ongoing;"Applied Microbiology and Biotechnology (Q3); Drug Discovery (Q3); Pharmacology (Q3)"
347;62892;Drug Discovery Today: BIOSILICO;journal;17418364;0,255;Q3;16;0;45;0;39;35;0,00;0,00;Netherlands;Elsevier BV;2003-2004;Drug Discovery (Q3)
348;21328;European Journal of Drug Metabolism and Pharmacokinetics;journal;03787966;0,247;Q3;34;29;111;525;53;105;0,53;18,10;France;Springer Paris;1976-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
349;17700155034;Natural product communications;journal;15559475, 1934578X;0,247;Q3;35;168;164;3989;67;158;0,42;23,74;United States;Natural Product Communications;2008-ongoing;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Plant Science (Q3)"
350;4700152607;Current Enzyme Inhibition;journal;15734080;0,245;Q3;15;25;29;3343;21;29;0,72;133,72;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Drug Discovery (Q3); Biochemistry (Q4); Molecular Medicine (Q4)"
351;5800228222;Journal of Pharmaceutical Innovation;journal;18725120;0,241;Q2;25;1;10;0;8;8;1,00;0,00;United States;Springer USA;2006-ongoing;"Pharmaceutical Science (Q2); Drug Discovery (Q3)"
352;25241;Toxicology Mechanisms and Methods;journal;15376524, 15376516;0,240;Q3;35;56;171;2270;129;162;0,83;40,54;United Kingdom;Taylor & Francis;1991-ongoing;"Toxicology (Q3); Health, Toxicology and Mutagenesis (Q4)"
353;130089;Toxin Reviews;journal;15569543, 15569551;0,239;Q3;38;16;80;1078;48;69;0,46;67,38;United Kingdom;Taylor & Francis;1982-ongoing;Toxicology (Q3)
354;11000153762;Journal of Immunotoxicology;journal;1547691X, 15476901;0,234;Q3;32;35;72;1393;48;70;0,60;39,80;United States;Taylor and Francis;2004-ongoing;"Toxicology (Q3); Immunology (Q4)"
355;5800173403;Recent Patents on Anti-Infective Drug Discovery;journal;1574891X;0,234;Q3;27;20;30;2144;24;30;0,80;107,20;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Drug Discovery (Q3); Infectious Diseases (Q3); Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3)"
356;19700180785;Studies in Natural Products Chemistry;book series;15725995;0,234;Q4;33;0;73;0;26;67;0,39;0,00;Netherlands;Elsevier BV;1995-1997, 2000-2003, 2005-2006, 2008, 2012-ongoing;"Drug Discovery (Q4); Organic Chemistry (Q4)"
357;22393;Indian Journal of Pharmacology;journal;02537613, 19983751;0,233;Q3;52;61;369;1318;167;235;0,64;21,61;India;Medknow Publications;1978-1980, 1982, 1984-1986, 1994-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
358;22212;Scientia Pharmaceutica;journal;22180532, 00368709;0,232;Q2;34;10;58;192;19;57;0,23;19,20;Austria;MDPI AG;1960-1961, 1973-ongoing;Pharmaceutical Science (Q2)
359;20065;BioPharm International;journal;1542166X;0,231;Q2;25;136;395;922;78;336;0,22;6,78;United States;UBM Medica Periodical Publication;2002-ongoing;"Pharmaceutical Science (Q2); Biotechnology (Q3)"
360;26767;Altex;journal;1868596X, 18688551;0,230;Q3;45;74;83;590;57;80;0,68;7,97;Germany;Spektrum Akademischer Verlag GmbH;2000-ongoing;"Medical Laboratory Technology (Q2); Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
361;24097;Journal of the Indian Chemical Society;journal;00194522;0,230;Q4;31;245;793;5100;272;781;0,29;20,82;India;Scientific Publishers;1973-1985, 1987-1991, 1996-ongoing;"Drug Discovery (Q4); Electrochemistry (Q4); Inorganic Chemistry (Q4); Organic Chemistry (Q4); Physical and Theoretical Chemistry (Q4)"
362;20599;Paediatric and Perinatal Drug Therapy;journal;14630095;0,230;Q3;17;21;51;477;31;43;0,75;22,71;United Kingdom;Librapharm Ltd.;1997-2008;"Pediatrics, Perinatology and Child Health (Q3); Pharmacology (Q3)"
363;21100791826;Journal of Traditional Medicines;journal;18813747, 18801447;0,228;Q4;9;30;98;715;35;97;0,37;23,83;Japan;Medical and Pharmaceutical Society for WAKAN-YAKU;2004, 2006-2007;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q4)"
364;22906;Journal of China Pharmaceutical University;journal;10005048;0,227;Q2;13;111;371;1229;106;371;0,26;11,07;China;China Pharmaceutical University;1989-1991, 2002-ongoing;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
365;94084;Drug Discovery Today: TARGETS;journal;17418372;0,226;Q4;15;0;64;0;30;54;0,00;0,00;Netherlands;Elsevier BV;2002-2004;Drug Discovery (Q4)
366;21082;Pharmaceutical Biology;journal;13880209, 17445116;0,226;Q3;53;130;375;3668;190;370;0,40;28,22;United Kingdom;Taylor & Francis;1961-1972, 1975-ongoing;"Complementary and Alternative Medicine (Q2); Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Pharmacology (Q3); Drug Discovery (Q4); Molecular Medicine (Q4)"
367;22908;Chinese Pharmacological Bulletin;journal;10011978;0,224;Q3;15;337;1120;4728;500;1120;0,50;14,03;China;Publication Centre of Anhui Medical University;1993-ongoing;Pharmacology (Q3)
368;26568;International Journal of Cosmetic Science;journal;01425463, 14682494;0,224;Q3;53;42;107;1487;83;104;0,63;35,40;United Kingdom;Blackwell Publishing Inc.;1979-ongoing;"Aging (Q3); Chemistry (miscellaneous) (Q3); Colloid and Surface Chemistry (Q3); Dermatology (Q3); Pharmaceutical Science (Q3); Drug Discovery (Q4)"
369;22357;IDrugs : the investigational drugs journal;journal;13697056;0,221;Q3;32;172;574;836;220;562;0,41;4,86;United Kingdom;Current Drugs Ltd.;1998-2010;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
370;21100389517;Drug Metabolism and Personalized Therapy;journal;23638907, 23638915;0,220;Q2;32;13;41;436;20;41;0,18;33,54;Germany;Walter de Gruyter GmbH;2015-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
371;4700151615;Scandinavian Journal of Work, Environment and Health, Supplement;journal;03566528;0,220;Q3;18;20;30;299;9;27;0,33;14,95;Finland;Nordic Association of Occupational Safety and Health (NOROSH);2005-2011, 2016-ongoing;"Geography, Planning and Development (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3); Health, Toxicology and Mutagenesis (Q4)"
372;5800173386;Current Drug Safety;journal;15748863;0,218;Q3;31;32;33;1861;21;33;0,64;58,16;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3); Toxicology (Q4)"
373;20684;Current Pharmacogenomics;journal;15701603;0,218;Q3;11;27;82;2689;46;82;0,58;99,59;United Arab Emirates;Bentham Science Publishers;2004-2007;"Pharmacology (Q3); Genetics (Q4)"
374;19383;Fluoride - Quarterly Reports;journal;00154725;0,216;Q4;41;33;147;755;137;124;1,12;22,88;New Zealand;International Society for Flouride Research;1973-ongoing;"Agricultural and Biological Sciences (miscellaneous) (Q2); Chemistry (miscellaneous) (Q3); Dentistry (miscellaneous) (Q3); Public Health, Environmental and Occupational Health (Q3); Biochemistry (Q4); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
375;5700165173;Journal of Medical Marketing;journal;17457912, 17457904;0,216;Q2;15;50;160;567;41;144;0,16;11,34;United States;SAGE Publications Inc.;2000-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Marketing (Q3); Medicine (miscellaneous) (Q3); Strategy and Management (Q3)"
376;19888;Medical Letter on Drugs and Therapeutics;journal;0025732X;0,215;Q3;18;56;203;417;93;194;0,54;7,45;United States;Medical Letter, Inc.;1965-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
377;25171;Mycotoxin Research;journal;01787888;0,215;Q4;31;34;121;669;47;112;0,45;19,68;Germany;Springer Verlag;1993-1995, 2008-ongoing;"Biotechnology (Q3); Microbiology (Q4); Toxicology (Q4)"
378;21100795043;Journal of Natural Remedies;journal;23203358, 09725547;0,214;Q3;16;42;93;968;24;92;0,21;23,05;India;Natural Remedies Pvt Ltd.;2002-ongoing;Pharmacology (Q3)
379;130007;Drug Design Reviews Online;journal;15672697;0,213;Q3;10;0;48;0;19;48;0,40;0,00;United Arab Emirates;Bentham Science Publishers;2005;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Molecular Medicine (Q4)"
380;16698;Revista Brasileira de Plantas Medicinais;journal;15160572;0,212;Q3;23;60;117;1847;22;114;0,15;30,78;Brazil;Fundacao do Instituto de Biociencias;1999-ongoing;"Complementary and Alternative Medicine (Q2); Pharmacology (Q3)"
381;4600151507;Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry;journal;18715230;0,211;Q3;19;30;141;3376;54;126;0,41;112,53;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Immunology and Allergy (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Immunology (Q4)"
382;16893;Biogenic Amines;journal;15693910, 01688561;0,211;Q3;14;31;76;1031;32;74;0,65;33,26;Netherlands;V S P;1989-2007;"Pharmacology (Q3); Neuroscience (miscellaneous) (Q4)"
383;4700152609;Current Computer-Aided Drug Design;journal;15734099;0,210;Q4;24;24;20;2269;12;18;0,67;94,54;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q3); Drug Discovery (Q4); Molecular Medicine (Q4)"
384;73076;Drug Discovery World;journal;14694344;0,210;Q4;10;48;67;365;24;60;0,37;7,60;United Kingdom;R J Communications & Media World Ltd.;2004-ongoing;Drug Discovery (Q4)
385;4500151530;Personalized Medicine;journal;17410541;0,209;Q3;24;52;42;1997;21;36;0,58;38,40;United Kingdom;Future Medicine Ltd.;2006-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
386;21758;Prescrire International;journal;11677422;0,209;Q3;11;154;361;914;83;229;0,36;5,94;France;Association Mieux Prescrire;1996-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
387;130006;Medicinal Chemistry Reviews - Online;journal;15672034;0,207;Q4;6;0;46;0;21;46;0,46;0,00;United Arab Emirates;Bentham Science Publishers;2005;"Drug Discovery (Q4); Molecular Medicine (Q4)"
388;21715;Pharmazeutische Industrie;journal;16167074, 0031711X;0,207;Q3;17;222;693;996;60;675;0,11;4,49;Germany;Editio Cantor Verlag;1960-1961, 1973-ongoing;Pharmaceutical Science (Q3)
389;19405;Acta Poloniae Pharmaceutica;journal;00016837;0,205;Q3;35;90;285;1672;81;285;0,21;18,58;Poland;Polskie Towarzystwo Farmaceutyczne/Polish Pharmaceutical Society;1951-1955, 1961-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
390;144963;Drug Discovery Today: Disease Models;journal;17406757;0,205;Q4;23;52;158;2134;56;150;0,26;41,04;Netherlands;Elsevier BV;2004-ongoing;"Drug Discovery (Q4); Molecular Medicine (Q4)"
391;23440;Indian Journal of Physiology and Pharmacology;journal;00195499;0,205;Q3;45;57;213;1174;98;178;0,45;20,60;India;All India Institute of Medical Sciences;1959-ongoing;"Pharmacology (Q3); Physiology (Q4); Physiology (medical) (Q4)"
392;4600151506;Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry;journal;18715222;0,204;Q3;14;38;139;4108;49;122;0,36;108,11;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Endocrinology, Diabetes and Metabolism (Q3); Pharmacology (Q3); Immunology and Allergy (Q4)"
393;21102;Pharmaceutical Journal;journal;00316873;0,203;Q3;25;952;6282;652;152;622;0,23;0,68;United Kingdom;Pharmaceutical Press;1945-1949, 1994-2012, 2014-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
394;4700151922;Research in Social and Administrative Pharmacy;journal;15517411;0,203;Q3;37;23;69;789;32;61;0,52;34,30;Netherlands;Elsevier BV;2005-ongoing;"Pharmacy (Q2); Pharmaceutical Science (Q3)"
395;25245;Veterinary and Human Toxicology;journal;01456296;0,203;Q4;36;0;116;0;108;108;0,00;0,00;United States;Comparative Toxicology Laboratories;1977-2004;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4); Veterinary (miscellaneous) (Q4)"
396;130045;Journal of Applied Biomedicine;journal;12140287, 1214021X;0,198;Q2;26;23;48;790;46;45;1,02;34,35;Spain;Elsevier Espana;2005-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Agricultural and Biological Sciences (miscellaneous) (Q3); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3); Neuroscience (miscellaneous) (Q4)"
397;26653;Journal of Herbal Pharmacotherapy;journal;15229106, 15228940;0,198;Q3;25;31;80;902;45;74;0,45;29,10;United States;The Haworth Herbal Press;2001-2007;"Pharmacology (Q3); Biochemistry (Q4)"
398;4000152107;Journal of Venomous Animals and Toxins Including Tropical Diseases;journal;16789199;0,195;Q4;22;35;60;1059;8;56;0,14;30,26;United Kingdom;BioMed Central;2006-ongoing;"Animal Science and Zoology (Q4); Infectious Diseases (Q4); Parasitology (Q4); Toxicology (Q4)"
399;145096;Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology;journal;14198711;0,194;Q3;14;27;88;275;29;73;0,43;10,19;Hungary;Neuroline;2004-ongoing;"Neurology (clinical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Neuropsychology and Physiological Psychology (Q4); Neuroscience (miscellaneous) (Q4)"
400;22854;Yakugaku Zasshi;journal;00316903;0,194;Q3;37;232;340;5710;183;337;0,57;24,61;Japan;Pharmaceutical Society of Japan;1961-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
401;12328;Current Therapeutic Research - Clinical and Experimental;journal;0011393X;0,189;Q3;34;39;130;1166;77;121;0,59;29,90;United States;Elsevier Inc.;1959-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
402;19399;Acta Pharmaceutica Hungarica;journal;00016659;0,188;Q3;12;30;74;778;14;74;0,13;25,93;Hungary;Magyar Gyogyszereszeti Tarsasag/Hungarian Pharmaceutical Association;1965-ongoing;"Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3)"
403;3200147837;Journal of Exercise Science and Fitness;journal;1728869X;0,188;Q3;17;12;23;494;8;20;0,40;41,17;Singapore;Elsevier (Singapore) Pte Ltd;2005-ongoing;"Pharmacology (nursing) (Q2); Pharmaceutical Science (Q3); Sports Science (Q4)"
404;79053;Natural Product Sciences;journal;12263907;0,186;Q4;22;52;166;1141;43;165;0,21;21,94;South Korea;Korean Society of Pharmacognosy;1997-ongoing;"Drug Discovery (Q4); Organic Chemistry (Q4)"
405;21077;Pharmaca;journal;00316857;0,184;Q3;4;16;31;308;7;29;0,15;19,25;Croatia;Association of Croatian Health Organizations;1989-2011;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
406;19700182901;Brazilian Journal of Pharmaceutical Sciences;journal;19848250, 21759790;0,183;Q3;32;72;181;2184;65;168;0,42;30,33;Brazil;Universidade de Sao Paulo;2009-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
407;35190;Revista Espanola de Quimioterapia;journal;02143429;0,179;Q3;23;51;146;1912;79;130;0,68;37,49;Spain;Sociedad Espaola de Quimioterapia;1989-ongoing;"Medicine (miscellaneous) (Q3); Microbiology (medical) (Q3); Pharmacology (Q3)"
408;20564;Ceska a Slovenska Farmacie;journal;12107816, 18054439;0,176;Q3;15;44;149;1370;41;149;0,35;31,14;Czech Republic;Nakladatelske Stredisko CLSJE Purkyne;1994-ongoing;Pharmaceutical Science (Q3)
409;23171;Korean Journal of Pharmacognosy;journal;02533073;0,174;Q3;14;71;178;1525;48;178;0,22;21,48;South Korea;Korean Society of Pharmacognosy;1990-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
410;21227;Pharmacy in Practice;journal;13581538;0,174;Q3;5;52;200;604;9;168;0,05;11,62;United Kingdom;Medicom Publishing;1995-2009;"Pharmacy (Q2); Health Policy (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
411;20710;DARU, Journal of Pharmaceutical Sciences;journal;15608115;0,173;Q3;33;33;104;803;34;104;0,26;24,33;United Kingdom;BioMed Central;2000-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
412;15842;Journal of Applied Research;journal;1537064X;0,173;Q3;18;28;186;731;60;178;0,39;26,11;United States;Therapeutic Solutions LLC;2001-2014;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
413;144613;Journal of Generic Medicines;journal;17411343;0,173;Q3;14;38;135;302;25;117;0,18;7,95;United Kingdom;SAGE Publications Inc.;2003-2017 (cancelled), 2017-2017 (cancelled);Pharmaceutical Science (Q3)
414;19700185200;Journal of Natural Medicines;journal;18610293;0,173;Q3;37;48;162;879;38;161;0,27;18,31;Germany;Springer Verlag;2006-ongoing;"Complementary and Alternative Medicine (Q2); Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Drug Discovery (Q4); Organic Chemistry (Q4)"
415;21127;Pharmaceutical Technology Europe;journal;17537967;0,172;Q3;16;99;295;813;39;180;0,25;8,21;United States;Advanstar Communications Inc.;1998-ongoing;Pharmaceutical Science (Q3)
416;130016;Cutaneous and Ocular Toxicology;journal;15569527, 15569535;0,171;Q4;25;34;76;1165;36;74;0,55;34,26;United Kingdom;Taylor & Francis;1982-2000, 2005-ongoing;"Medicine (miscellaneous) (Q3); Toxicology (Q4)"
417;19381;Acta Farmaceutica Bonaerense;journal;03262383;0,168;Q3;21;0;284;0;79;284;0,23;0,00;Argentina;Colegio de Farmaceuticos de la Provincia de Buenos Aires;1989-2006;"Pharmaceutical Science (Q3); Drug Discovery (Q4)"
418;110097;Food and Drug Law Journal;journal;1064590X;0,168;Q3;18;42;101;3769;30;99;0,31;89,74;United States;Food and Drug Law Institute;1992-ongoing;"Law (Q2); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Public Health, Environmental and Occupational Health (Q3)"
419;22934;Chinese Pharmaceutical Journal;journal;10012494;0,167;Q3;19;423;1292;3789;191;1292;0,14;8,96;China;Zhonogguo Yaoxuehui;1993-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
420;4700152903;Forensic Toxicology;journal;18608965, 18608973;0,167;Q4;30;20;47;331;24;45;0,62;16,55;Germany;Springer Verlag;2006-ongoing;"Biochemistry (medical) (Q3); Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
421;13718;Pharmaceutical Engineering;journal;02738139;0,167;Q3;13;58;167;368;14;149;0,08;6,34;United States;International Society for Pharmaceutical Engineering, Inc.;1996-ongoing;Pharmaceutical Science (Q3)
422;22825;Proceedings of the Western Pharmacology Society;journal;00838969;0,166;Q3;22;40;127;1040;43;127;0,27;26,00;United States;Western Pharmacology Society, Inc.;1960-1969, 1973-2011;Pharmacology (Q3)
423;5900153312;Recent Patents on Cardiovascular Drug Discovery;journal;15748901;0,160;Q4;25;27;26;2300;8;26;0,31;85,19;United Arab Emirates;Bentham Science Publishers;2006-2015;"Cardiology and Cardiovascular Medicine (Q3); Pharmacology (medical) (Q3); Drug Discovery (Q4)"
424;21795;Farmaceuticky Obzor;journal;00148172;0,159;Q3;7;35;89;631;9;89;0,12;18,03;Slovakia;Ministerstvo Zdravotnictva;1961-1963, 1974, 1976-2016 (cancelled);Pharmaceutical Science (Q3)
425;4000148821;International Journal of Pharmaceutical Compounding;journal;10924221;0,159;Q3;9;73;119;563;9;107;0,08;7,71;United States;International Journal of Pharmaceutical Compounding (Ijpc);2006-ongoing;"Pharmacology (nursing) (Q2); Pharmacy (Q2); Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Pharmacology (medical) (Q3)"
426;3500148011;Journal of Zhejiang University: Science B;journal;16731581;0,158;Q3;45;128;189;1271;135;184;0,73;9,93;China;Zhejiang University Press;2005-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Veterinary (miscellaneous) (Q4)"
427;19700182122;Pharmaceuticals Policy and Law;journal;2210495X, 13892827;0,158;Q3;9;34;61;595;7;60;0,12;17,50;Netherlands;IOS Press;2010-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Health Policy (Q4)"
428;19978;Ars Pharmaceutica;journal;00042927, 23409894;0,156;Q3;18;24;80;681;25;78;0,30;28,38;Spain;Editorial Universidad de Granada;1980-1981, 1983-1984, 1986-2001, 2003-2017 (cancelled);"History and Philosophy of Science (Q3); Pharmaceutical Science (Q3)"
429;4700152769;Pharmacopeial Forum;journal;03634655;0,156;Q4;16;7;84;75;15;38;0,21;10,71;United States;Pharmacopeia;1996-1998, 2000-2017 (cancelled);"Pharmacy (Q2); Drug Guides (Q3); Pharmacology (Q4)"
430;21412;Zeitschrift fr Phytotherapie : offizielles Organ der Ges. f. Phytotherapie e.V;journal;0722348X;0,156;Q4;12;61;173;739;33;125;0,36;12,11;Germany;Hippokrates Verlag;1982, 1985-ongoing;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
431;24605;Arhiv za Higijenu Rada i Toksikologiju;journal;18486312, 00041254;0,152;Q4;26;44;116;1458;29;116;0,24;33,14;Croatia;Institute for Medical Research and Occupational Health;1953-ongoing;"Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
432;18384;Medicinal Chemistry Research;journal;10542523;0,152;Q3;38;45;275;1302;52;275;0,06;28,93;United States;Birkhauser Boston;1994, 1996-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Organic Chemistry (Q4)"
433;22205;Saudi Pharmaceutical Journal;journal;13190164;0,152;Q3;36;27;75;1017;14;74;0,16;37,67;Saudi Arabia;King Saud University;1996-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
434;22338;Hospital Pharmacy;journal;00185787;0,150;Q4;21;126;412;1519;50;362;0,13;12,06;United States;Thomas Land Publishers Inc.;1973-ongoing;"Pharmacology (medical) (Q3); Pharmacy (Q3); Pharmacology (Q4)"
435;5800173387;Reviews on Recent Clinical Trials;journal;15748871;0,150;Q4;30;26;30;2076;6;29;0,21;79,85;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (Q4)"
436;21811;Farmacia Hospitalaria;journal;11306343;0,149;Q4;21;84;238;1690;89;156;0,68;20,12;Spain;Aran Ediciones SA;1990-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (Q4)"
437;50105;Japanese Journal of Neuropsychopharmacology;journal;13434144;0,149;Q4;9;27;107;869;22;107;0,15;32,19;Japan;Nihon Shinkei Seishin Yakuri Gakkai/Japanese Society of Neuropsychophamacology;1982-1997, 2002-ongoing;"Pharmacology (medical) (Q3); Clinical Psychology (Q4); Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
438;4700152233;Therapeutics and Clinical Risk Management;journal;11766336;0,148;Q3;43;122;47;6698;11;43;0,26;54,90;New Zealand;Dove Medical Press Ltd;2006-ongoing;"Chemical Health and Safety (Q3); Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Safety Research (Q3)"
439;145689;Alimentary Pharmacology and Therapeutics Symposium Series;journal;17466334;0,146;Q3;9;5;53;67;15;53;0,28;13,40;United Kingdom;Blackwell Publishing Inc.;2005-2007;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
440;25247;Chinese Journal of Pharmacology and Toxicology;journal;10003002;0,146;Q4;11;79;248;1323;45;247;0,19;16,75;China;Chung-Kuo Yao Li Hseuh Hui;1986-ongoing;"Pharmacology (Q4); Toxicology (Q4)"
441;4700152608;African Journal of Traditional, Complementary and Alternative Medicines;journal;01896016;0,145;Q4;36;64;43;1494;19;42;0,45;23,34;Nigeria;African Networks on Ethnomedicines;1970, 1973-1978, 1981-1982, 1991, 1995, 2002, 2006-2016 (cancelled);"Complementary and Alternative Medicine (Q3); Medicine (miscellaneous) (Q3); Drug Discovery (Q4)"
442;6400153120;Chinese Medicine;journal;17498546;0,145;Q4;34;12;4;842;1;3;0,33;70,17;United Kingdom;BioMed Central;2006-ongoing;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
443;4700152701;Pharmacy Practice;journal;1885642X, 18863655;0,145;Q3;19;30;25;636;5;25;0,20;21,20;Spain;Centro de Investigaciones y Publicaciones Farmaceuticas;2006-ongoing;"Pharmaceutical Science (Q3); Pharmacy (Q3)"
444;5200152602;Acta Pharmaceutica Sciencia;journal;13072080;0,144;Q3;15;15;69;402;9;68;0,02;26,80;Turkey;Istanbul Medipol University;2006-2011, 2016-ongoing;Pharmaceutical Science (Q3)
445;4100151616;Supportive Cancer Therapy;journal;15432912;0,143;Q4;13;28;38;724;6;29;0,21;25,86;United States;Cancer Information Group;2006-2007;"Oncology (Q3); Cancer Research (Q4); Pharmacology (Q4)"
446;19461;Annales Pharmaceutiques Francaises;journal;00034509;0,141;Q3;22;40;162;1179;47;157;0,35;29,48;France;Elsevier Masson;1946-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
447;145693;Canadian Pharmacists Journal;journal;17151635;0,141;Q3;18;136;424;719;23;239;0,13;5,29;Canada;Canadian Pharmacists Association;2005-ongoing;"Pharmaceutical Science (Q3); Pharmacy (Q3)"
448;19700180827;Progress in Pharmaceutical and Biomedical Analysis;book series;14643456;0,140;Q3;7;0;14;0;4;12;0,33;0,00;United Kingdom;Elsevier Science;1996, 2000, 2003, 2005;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biochemistry (Q4); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Biomedical Engineering (Q4); Biotechnology (Q4)"
449;22937;Zhongguo Zhongyao Zazhi;journal;10015302;0,140;Q3;26;533;1179;5807;249;1179;0,20;10,89;China;Zhongguo Zhongyi Yanjiuyuan;1989-ongoing;"Complementary and Alternative Medicine (Q3); Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
450;130170;Phytotherapie;journal;17652847, 16248597;0,139;Q4;12;63;100;636;3;68;0,04;10,10;Germany;Springer Verlag;2005-ongoing;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
451;3300147901;EMC - Toxicologie-Pathologie;journal;17625858;0,137;Q4;5;0;30;0;7;29;0,29;0,00;France;Editions scientifique et medicales Elsevier SAS;2004-2005;"Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
452;10300153342;Journal of medical toxicology : official journal of the American College of Medical Toxicology;journal;15569039;0,137;Q4;41;37;49;103;8;40;0,20;2,78;United States;Springer New York LLC;2005-ongoing;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
453;4800154015;S.T.P. Pharma Pratiques;journal;11571497;0,136;Q3;9;36;118;324;11;117;0,11;9,00;France;Editions de Sante;1991-2014, 2017-ongoing;Pharmaceutical Science (Q3)
454;21718;Pharmazie in Unserer Zeit;journal;00483664, 16151003;0,135;Q3;12;50;235;517;35;195;0,22;10,34;United Kingdom;John Wiley & Sons Ltd.;1972-2012;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Pharmacology (Q4)"
455;4000148204;Pakistan Journal of Pharmaceutical Sciences;journal;1011601X;0,134;Q3;35;50;115;376;34;114;0,30;7,52;Pakistan;University of Karachi;2005-ongoing;Pharmaceutical Science (Q3)
456;4700152283;Revista de Ciencias Farmaceuticas Basica e Aplicada;journal;18084532;0,134;Q3;14;45;110;1467;12;107;0,11;32,60;Brazil;Universidade Estadual Paulista (UNESP);2005-ongoing;Pharmaceutical Science (Q3)
457;25197;Revista de Toxicologia;journal;16970748, 02127113;0,134;Q4;9;12;59;259;13;59;0,14;21,58;Spain;Asociacion Espanola de Toxicologia;1989-2017 (cancelled);Toxicology (Q4)
458;23173;Korean Journal of Physiology and Pharmacology;journal;12264512;0,133;Q4;23;35;148;1167;13;146;0,12;33,34;South Korea;Eui-Hak Publishing and Printing Co.;1997-ongoing;"Pharmacology (Q4); Physiology (Q4)"
459;3900148201;International Journal of Pharmacology;journal;18125700, 18117775;0,132;Q4;29;92;113;2520;29;113;0,26;27,39;Pakistan;Asian Network for Scientific Information;2006-ongoing;Pharmacology (Q4)
460;22979;Journal of Applied Therapeutic Research;journal;10292659;0,132;Q4;7;4;34;93;9;34;0,07;23,25;United Kingdom;Euromed Communications;1998-2000, 2003-2012;Pharmacology (Q4)
461;23107;Journal of Pharmacy Technology;journal;87551225;0,132;Q3;9;31;125;712;14;103;0,15;22,97;United States;SAGE Publications Inc.;1989-ongoing;Pharmaceutical Science (Q3)
462;19700189100;Pharmaceutical Medicine;journal;11782595, 14735679;0,131;Q4;15;51;113;1128;17;95;0,21;22,12;United Kingdom;Adis International Ltd.;2008-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
463;19982;Asia Pacific Journal of Pharmacology;journal;02179687;0,130;Q4;9;0;21;0;8;20;0,00;0,00;Singapore;Singapore University Press;1986-1998, 2000-2001, 2003-2004, 2006;Pharmacology (Q4)
464;25425;Journal of Herbs, Spices and Medicinal Plants;journal;15403580, 10496475;0,130;Q4;24;11;55;403;10;55;0,17;36,64;United States;The Haworth Herbal Press;1992-ongoing;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
465;4000151610;International Journal of Neuroprotection and Neurogeneration;journal;17451183, 17451191;0,127;Q4;5;18;26;590;8;24;0,33;32,78;United Kingdom;RPA Publishers.;2006-2008;"Neurology (clinical) (Q4); Pharmacology (Q4)"
466;21828;Revista Cubana de Farmacia;journal;00347515, 15612988;0,126;Q3;8;39;106;636;8;103;0,12;16,31;Cuba;Editorial Ciencias Medicas;1980-1991, 1996-2000, 2002, 2004-ongoing;"Pharmaceutical Science (Q3); Pharmacy (Q3); Pharmacology (Q4)"
467;21840;Folia Pharmacologica Japonica;journal;00155691, 13478397;0,125;Q4;17;123;344;2265;49;333;0,08;18,41;Japan;Nippon Yakuri Gakkai;1961-ongoing;Pharmacology (Q4)
468;10900153328;Frontiers in Drug Design and Discovery;book series;15672042;0,124;Q4;8;23;18;2910;5;17;0,29;126,52;United Arab Emirates;Bentham Science Publishers;2006-2009;"Drug Discovery (Q4); Molecular Medicine (Q4); Pharmaceutical Science (Q4)"
469;23074;Journal of Pharmaceutical Finance, Economics and Policy;journal;15385396, 15385698;0,124;Q4;7;11;49;510;8;42;0,16;46,36;United States;Haworth Press Inc.;2003-2008;"Health Policy (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
470;21086;Pharmaceutical Chemistry Journal;journal;15739031, 0091150X;0,124;Q4;26;156;455;2524;40;455;0,07;16,18;United States;Kluwer Academic/Plenum Publishers;1967-1977, 1979-1994, 1996-ongoing;"Drug Discovery (Q4); Pharmacology (Q4)"
471;5100152903;Revista Cubana de Plantas Medicinales;journal;10284796;0,124;Q4;11;22;33;276;0;30;0,00;12,55;Cuba;Editorial Ciencias Medicas;1996-1997, 1999-2002, 2005-ongoing;"Drug Discovery (Q4); Pharmacology (Q4); Plant Science (Q4)"
472;5100152606;Biosciences Biotechnology Research Asia;journal;09731245, 24562602;0,123;Q4;13;142;195;2326;7;194;0,04;16,38;India;Oriental Scientific Pub. Co.;2005-2016 (cancelled);"Agronomy and Crop Science (Q4); Biotechnology (Q4); Drug Discovery (Q4)"
473;21716;Pharmazeutische Zeitung;journal;00317136;0,123;Q4;7;382;1379;910;7;637;0,01;2,38;Germany;Govi Verlag Pharmazeutischer Verlag GmbH;1947-1948, 1985-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
474;17716;Quality Assurance Journal;journal;10991786, 10878378;0,123;Q4;7;26;97;167;13;84;0,23;6,42;United States;John Wiley & Sons Inc.;1998, 2000-2007, 2009-2011;"Medicine (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
475;21329;European Journal of Herbal Medicine;journal;13524755;0,122;Q4;2;0;5;0;0;1;0,00;0,00;United Kingdom;National Institute of Medical Herbalists;2001-2004;Pharmacology (Q4)
476;19700201521;Journal of Chemical and Pharmaceutical Research;journal;09757384;0,122;Q4;29;0;1;0;0;1;0,00;0,00;India;JOCPR;2011-2014 (cancelled);Pharmaceutical Science (Q4)
477;15892;Journal of Drug Evaluation;journal;14791137;0,121;Q4;4;0;25;0;3;10;0,00;0,00;United Kingdom;Parthenon Publishing Group;2003-2004;"Pharmacology (Q4); Pharmacy (Q4)"
478;21836;Revista Mexicana de Ciencias Farmaceuticas;journal;10273956;0,121;Q4;8;26;91;681;4;68;0,09;26,19;Mexico;Asociacion Farmaceutica Mexicana;1997-2015;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
479;130150;Advances in Pharmacy;journal;15323862;0,120;Q4;1;0;25;0;1;16;0,06;0,00;United States;Facts and Comparisons;2005;Pharmaceutical Science (Q4)
480;21374;Fabad Journal of Pharmaceutical Sciences;journal;13004182;0,120;Q4;14;24;90;877;9;85;0,10;36,54;Turkey;Society of Pharmaceutical Sciences of Ankara;1999-2001, 2003-ongoing;Pharmaceutical Science (Q4)
481;130031;Journal of Toxicologic Pathology;journal;09149198;0,120;Q4;20;24;93;891;13;93;0,19;37,13;Japan;Nihon Dokusei Byori Gakkai;1998-2002, 2004-ongoing;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
482;5000158117;Profiles of Drug Substances, Excipients and Related Methodology;book series;18715125;0,120;Q4;15;6;23;121;3;21;0,14;20,17;United States;Elsevier Inc.;2001-2003, 2005, 2007-ongoing;"Medicine (miscellaneous) (Q4); Molecular Medicine (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
483;110141;Sangyo eiseigaku zasshi = Journal of occupational health;journal;13410725;0,120;Q4;11;16;53;0;11;53;0,15;0,00;Japan;Nihon Sangyo Eisei Gakkai;1995-ongoing;"Medicine (miscellaneous) (Q4); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
484;22858;Japanese Pharmacology and Therapeutics;journal;03863603;0,119;Q4;13;88;203;1319;12;203;0,07;14,99;Japan;Life Science Publishing Co. Ltd.;1981-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
485;80593;Journal of Medicinal Plants;journal;16840240;0,118;Q4;16;53;125;1155;9;125;0,04;21,79;Iran;Pizhuhishkadh-i giyahan-i darayiva faravardah ha-vi tabbii;2004-ongoing;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
486;4000148308;Chinese Traditional and Herbal Drugs;journal;02532670;0,117;Q4;13;301;223;3378;20;223;0,09;11,22;China;Chung Tsao Yao Tsa Chih Pien Chi Pu;2006-ongoing;"Complementary and Alternative Medicine (Q3); Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
487;25196;Revista Brasileira de Toxicologia;journal;14152983;0,117;Q4;6;10;34;363;1;33;0,04;36,30;Brazil;Sociedade Brasileira de Toxicologia;2000-2010;Toxicology (Q4)
488;21100463829;Chinese Journal of Population Resources and Environment;journal;23254262, 10042857;0,116;Q4;9;55;113;766;5;112;0,06;13,93;United Kingdom;Taylor and Francis Ltd.;2015-ongoing;"Demography (Q4); Environmental Science (miscellaneous) (Q4); Toxicology (Q4)"
489;21279;Eksperimental'naya i Klinicheskaya Farmakologiya;journal;08692092;0,116;Q4;13;88;322;1873;31;322;0,11;21,28;Russian Federation;Izdatel'stvo Meditsina Publishers;1992-ongoing;"Medicine (miscellaneous) (Q4); Pharmacology (Q4); Toxicology (Q4)"
490;20572;PZ Prisma;journal;09455566;0,116;Q4;5;19;101;433;4;88;0,05;22,79;Germany;Govi Verlag Pharmazeutischer Verlag GmbH;1994-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
491;22887;Chinese Journal of Antibiotics;journal;10018689;0,115;Q4;10;149;592;2122;34;585;0,06;14,24;China;Editorial Office of the Chinese Journal of Antibiotics;1983-2015;Pharmacology (Q4)
492;22514;Japanese Journal of Chemotherapy;journal;13407007;0,115;Q4;12;39;184;637;12;184;0,05;16,33;Japan;Nihon Kagaku Ryoho Gakkai/Japan Society of Chemotherapy;1995-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
493;144879;Toxicology International;journal;09716580;0,115;Q4;21;26;40;520;5;39;0,13;20,00;India;Society of Toxicology;2005-ongoing;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
494;86688;Acta Toxicologica;journal;17316383;0,114;Q4;7;21;50;497;3;47;0,10;23,67;Poland;Instytut Medycyny Pracy im. Jerzego Nofera/Nofer Institute of Occupational Medicine;2003-2007;Toxicology (Q4)
495;19430;Adverse Drug Reaction Bulletin;journal;00446394;0,114;Q4;7;6;17;245;4;16;0,10;40,83;United States;Lippincott Williams & Wilkins Ltd.;1970, 1973-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
496;70864;Anales de la Real Academia Nacional de Farmacia;journal;1697428X, 16974271;0,114;Q4;8;52;99;2104;9;97;0,08;40,46;Spain;Real Academia Nacional de Farmacia;2004-2005;"Cell Biology (Q4); Molecular Biology (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
497;21292;Epitheorese Klinikes Farmakologias kai Farmakokinetikes;journal;10116575;0,113;Q4;4;47;96;499;2;96;0,02;10,62;Bulgaria;Pharmakon Press;1989-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
498;21142;Pharmaceutisch Weekblad;journal;00316911;0,113;Q4;9;392;1719;343;12;1128;0,01;0,88;Netherlands;Royal Netherlands Pharmaceutical Society;1948-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
499;21867;Geneesmiddelenbulletin;journal;03044629;0,112;Q4;6;49;197;117;3;33;0,09;2,39;Netherlands;Stichting Geneesmiddelenbulletin;1973-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
500;19700181403;Pharmaceutical Outsourcing;journal;19453337, 19453345;0,112;Q4;5;35;128;164;4;118;0,01;4,69;United States;Russell Publishing LLC;2010-ongoing;"Health Policy (Q4); Pharmaceutical Science (Q4)"
501;6400153143;Turkish Journal of Pharmaceutical Sciences;journal;1304530X;0,112;Q4;11;16;15;365;1;15;0,07;22,81;Turkey;Turkish Pharmacists Association;2006-ongoing;"Molecular Medicine (Q4); Pharmaceutical Science (Q4)"
502;4100151606;Actualites Pharmaceutiques Hospitalieres;journal;17697344;0,111;Q4;2;22;73;132;1;64;0,02;6,00;Netherlands;Elsevier BV;2005-2012;Pharmaceutical Science (Q4)
503;15680;Giornale di Neuropsicofarmacologia;journal;03919048;0,111;Q4;1;12;65;129;1;57;0,03;10,75;Italy;C I C Edizioni International srl;1996-2008;"Neurology (clinical) (Q4); Neuropsychology and Physiological Psychology (Q4); Neuroscience (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
504;89630;Psychopharmakotherapie, Supplement;journal;09465146;0,111;Q4;2;10;37;112;1;30;0,04;11,20;Germany;Wissenschaftliche Verlagsgesellschaft;1997-1999, 2004-2005, 2007-2008;"Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
505;21100197160;Research Journal of Pharmacy and Technology;journal;09743618, 0974360X;0,111;Q4;14;0;2;0;0;2;0,00;0,00;India;A and V Publication;2011-ongoing;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
506;20627;Clinical Research and Regulatory Affairs;journal;15322521, 10601333;0,110;Q4;14;8;38;172;4;36;0,13;21,50;United States;Marcel Dekker Inc.;1983-1990, 1992-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
507;4000151703;Core Evidence;journal;15551741, 1555175X;0,110;Q4;19;10;20;726;2;19;0,11;72,60;United States;Core Medical Pub;2005-ongoing;"Reviews and References (medical) (Q1); Medicine (miscellaneous) (Q4); Pharmacology (Q4)"
508;21334;EPC - European Pharmaceutical Contractor;journal;1364369X;0,110;Q4;3;87;282;193;3;255;0,01;2,22;United Kingdom;Samedan Ltd.;2002-ongoing;Pharmaceutical Science (Q4)
509;22977;Journal de Pharmacie de Belgique;journal;00472166;0,110;Q4;12;22;60;315;8;59;0,22;14,32;Belgium;Algemene Pharmaceutische Bond;1946-2015;"Medicine (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
510;20661;Current Drug Discovery;journal;14727463;0,109;Q4;12;0;97;0;10;52;0,00;0,00;United Kingdom;Current Drugs Ltd.;2002-2004;Pharmacology (Q4)
511;9100153105;Current Topics in Pharmacology;journal;09724559;0,108;Q4;4;18;18;1118;2;18;0,11;62,11;India;Research Trends;2006-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
512;21100198011;Current Protocols in Pharmacology;journal;19348282, 19348290;0,107;Q4;22;13;50;0;2;50;0,06;0,00;United States;John Wiley and Sons Inc.;2001-ongoing;"Medicine (miscellaneous) (Q4); Pharmacology (Q4)"
513;50087;EBR - European Biopharmaceutical Review;journal;13690663;0,107;Q4;5;93;274;534;6;248;0,03;5,74;United Kingdom;Samedan Ltd.;2004-ongoing;Pharmaceutical Science (Q4)
514;11100153314;Frontiers in Medicinal Chemistry;book series;15740889;0,107;Q4;6;0;27;0;5;26;0,19;0,00;United Arab Emirates;Bentham Science Publishers;2006, 2009-2010;"Drug Discovery (Q4); Molecular Medicine (Q4); Organic Chemistry (Q4)"
515;20628;Circular Farmaceutica;journal;00097314;0,106;Q4;2;40;122;322;2;107;0,03;8,05;Spain;Colegio Official de Farmaceuticos de la Provincia de Barcelona;1961, 1973-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
516;19700188399;Current Protocols in Toxicology;journal;19349254, 19349262;0,106;Q4;18;17;53;0;5;53;0,14;0,00;United Kingdom;John Wiley & Sons Ltd.;2001-ongoing;"Medicine (miscellaneous) (Q4); Toxicology (Q4)"
517;58808;Pharmaceutical Care and Research;journal;16712838;0,106;Q4;7;109;319;978;10;316;0,03;8,97;China;Yao xue fu wu yu yan jiu za zhi she;2004-ongoing;"Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
518;27715;Anil Aggrawal's Internet Journal of Forensic Medicine and Toxicology;journal;09728074;0,105;Q4;9;11;41;201;4;28;0,00;18,27;India;Anil Aggrawal;2000-ongoing;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
519;88685;Annual Report of Shionogi Research Laboratory;journal;05598680;0,105;Q4;2;2;4;180;0;4;0,00;90,00;Japan;Research Laboratory of Shionogi and Co.;1972-1974, 1987-2009, 2015;Pharmacology (Q4)
520;5200152843;Farmaceutico Hospitales;journal;02144697;0,105;Q4;3;45;8;520;0;4;0,00;11,56;Spain;Ediciones Mayo;2006-2009;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
521;17700156431;Handbook of Analytical Separations;book series;15677192;0,105;Q4;11;32;14;4856;2;0;0,00;151,75;Netherlands;Elsevier BV;2000-2001, 2003-2004, 2007;"Analytical Chemistry (Q4); Environmental Chemistry (Q4); Pathology and Forensic Medicine (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
522;21907;Journal of Anaesthesiology Clinical Pharmacology;journal;09709185;0,105;Q4;25;95;304;1386;6;214;0,04;14,59;India;Medknow Publications;1996-1999, 2002-ongoing;"Anesthesiology and Pain Medicine (Q4); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
523;17783;Research Communications in Molecular Pathology and Pharmacology;journal;10780297;0,105;Q4;37;11;44;0;2;44;0,00;0,00;United States;PJD Publications Ltd.;1994-2007, 2009;"Medicine (miscellaneous) (Q4); Molecular Medicine (Q4); Pharmacology (Q4)"
524;19600162009;Advances in Molecular Toxicology;book series;18720854;0,104;Q4;10;0;6;0;0;5;0,00;0,00;Netherlands;Elsevier BV;2006, 2008-ongoing;"Health, Toxicology and Mutagenesis (Q4); Pharmacology (Q4); Toxicology (Q4)"
525;21238;Drug Topics;journal;00126616;0,104;Q4;7;358;1564;0;16;1331;0,01;0,00;United States;Advanstar Communications Inc.;1991, 1997-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
526;72164;Journal of Infectious Disease Pharmacotherapy;journal;10687777;0,104;Q4;6;0;6;0;0;6;0,00;0,00;United States;Pharmaceutical Products Press;1996, 1998-1999, 2001-2004;"Microbiology (medical) (Q4); Pharmacology (Q4)"
527;21083;Pharmaceutical Care Espana;journal;11396202;0,104;Q4;9;26;91;464;12;76;0,12;17,85;Spain;Fundacion Pharamaceutical Care Espana;2001-2016 (cancelled);"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
528;19700175108;Drug Delivery System;journal;09135006;0,103;Q4;7;30;116;570;4;116;0,05;19,00;Japan;Japan Society of Drug Delivery System;2009-ongoing;Pharmaceutical Science (Q4)
529;15323;Journal of Jilin University Medicine Edition;journal;1671587X;0,103;Q4;5;290;512;2636;9;512;0,02;9,09;China;Jilin University;2005-ongoing;Pharmacology (Q4)
530;19700180757;Advances in Phytomedicine;book series;1572557X;0,102;Q4;12;0;43;0;1;39;0,03;0,00;Netherlands;Elsevier BV;2002, 2006;"Drug Discovery (Q4); Plant Science (Q4)"
531;19459;Ankara Universitesi Eczacilik Fakultesi Dergisi;journal;10153918;0,102;Q4;9;15;62;395;4;62;0,00;26,33;Turkey;Ankara Universitesi;1997-2001, 2003-2010, 2014, 2016-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
532;21932;Hindustan Antibiotics Bulletin;journal;00181935;0,102;Q4;8;7;9;0;0;9;0,00;0,00;India;Hindustan Antibiotics Ltd.;1960-1961, 1965-2000, 2002-2003, 2005, 2007;Pharmacology (Q4)
533;18098;Japanese Journal of Psychopharmacology;journal;13402544;0,102;Q4;11;0;9;0;0;9;0,00;0,00;Japan;Nihon Shinkei Seishin Yakuri Gakkai/Japanese Society of Neuropsychophamacology;1981-2017;"Clinical Psychology (Q4); Medicine (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
534;19900191564;Journal of International Peacekeeping;journal;18754104, 18754112;0,102;Q4;8;0;49;0;5;46;0,14;0,00;Netherlands;Brill;1995, 1997, 2001, 2006, 2013-ongoing;"Infectious Diseases (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Virology (Q4)"
535;4700151603;Journal of Pharmacy of Istanbul University;journal;03677524;0,102;Q4;7;14;11;169;0;11;0,00;12,07;Turkey;Istanbul Universitesi Eczacilik Fakultesi;2005, 2007-2008, 2010, 2012, 2015-ongoing;"Pharmaceutical Science (Q4); Pharmacy (Q4)"
536;13637;Manufacturing Chemist;journal;02624230;0,102;Q4;6;69;10;117;0;9;0,00;1,70;United Kingdom;Polygon Media Ltd.;1981-1984, 1986, 1989, 1996-2001, 2006-ongoing;Pharmaceutical Science (Q4)
537;21100239829;Current Issues in Pharmacy and Medical Sciences;journal;2084980X, 23006676;0,101;Q4;7;5;23;102;1;23;0,05;20,40;Poland;Uniwersytet Medyczny w Lublinie;2012-ongoing;"Biochemistry (Q4); Medicine (miscellaneous) (Q4); Molecular Biology (Q4); Pharmacology (Q4)"
538;4700152278;Drugs in Context;journal;17404398, 17451981;0,101;Q4;12;11;44;265;0;33;0,00;24,09;United Kingdom;BioExcel Publishing Ltd;2006-2008, 2012-ongoing;"Molecular Medicine (Q4); Pharmacology (Q4)"
539;144718;Enhancer - Biotherapy of Cancer;journal;15720004;0,101;Q4;0;0;43;0;0;21;0,00;0,00;United States;Duke University Press;2005-2006;"Cancer Research (Q4); Drug Discovery (Q4); Immunology (Q4); Immunology and Allergy (Q4); Oncology (Q4)"
540;20778;EOS Rivista di Immunologia ed Immunofarmacologia;journal;03926699;0,101;Q4;5;0;17;0;0;17;0,00;0,00;Italy;Sigma-Tau SpA;1983-2001, 2003-2004;"Immunology (Q4); Pharmacology (Q4)"
541;21823;Farmatsija;journal;04280296;0,101;Q4;5;8;83;136;3;83;0,04;17,00;Bulgaria;Meditsinski Universitet - Sofia;1945, 1954-1955, 1987-1991, 1997-ongoing;"Pharmaceutical Science (Q4); Pharmacology (medical) (Q4); Pharmacy (Q4)"
542;19700180822;Immunotoxicology of Drugs and Chemicals: an Experimental and Clinical Approach;book series;18739822;0,101;Q4;2;0;17;0;2;16;0,00;0,00;Netherlands;Elsevier BV;2004;"Immunology (Q4); Toxicology (Q4)"
543;25110;International Journal of Medical Toxicology and Legal Medicine;journal;09720448;0,101;Q4;8;27;31;348;3;31;0,10;12,89;India;All India Institute of Medical Sciences;1999-2003, 2005-2011, 2017-ongoing;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
544;11100153311;Iranian Journal of Pharmacology and Therapeutics;journal;17352657;0,101;Q4;18;39;31;1121;2;31;0,06;28,74;Iran;Razi Institute for Drug Research of IUMS;2006-2015;Pharmacology (Q4)
545;78698;Japanese Journal of Clinical Pharmacology and Therapeutics;journal;03881601;0,101;Q4;7;9;176;117;1;165;0,01;13,00;Japan;Nihon Rinsho Yakuri Gakkai/Japanese Society of Clinical Pharmacology and Therapeutics;1987-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
546;20543;Pharmacometrics;journal;03008533;0,101;Q4;6;0;34;0;0;33;0,00;0,00;Japan;Japanese Society or Pharmacometrics;1973-2004, 2009-2012;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
547;5000158120;Pharmacy News;journal;1448207X;0,101;Q4;1;307;59;24;0;21;0,00;0,08;Spain;Reed Business Information Ltd;2006-2011;"Pharmacology (nursing) (Q3); Pharmaceutical Science (Q4)"
548;5200152604;Pharma Times;journal;00316849;0,101;Q4;10;71;25;512;0;22;0,00;7,21;India;Indian Pharmaceutical Association;2006-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
549;145000;Signal;journal;14719967;0,101;Q4;1;5;29;131;1;16;0,06;26,20;United Kingdom;Adis International Ltd.;2005-2007;"Drug Discovery (Q4); Oncology (Q4); Pharmacology (medical) (Q4)"
550;19408;Actualites Pharmaceutiques;journal;05153700;0,100;Q4;5;187;469;136;0;323;0,00;0,73;Netherlands;Elsevier BV;1961, 1963, 1996-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
551;17744;Anales de la Real Academia Nacional de Medicina;journal;00340634;0,100;Q4;6;40;134;96;3;134;0,00;2,40;Spain;Real Academia Nacional de Medicina;1949-2011;"Cell Biology (Q4); Medicine (miscellaneous) (Q4); Molecular Biology (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
552;9500153932;Ciencia y Tecnologia Pharmaceutica;journal;15753409;0,100;Q4;6;6;71;55;2;59;0,05;9,17;Spain;Alpe Editores;1996-2007;Pharmacology (Q4)
553;5100154302;European Biotechnology Science and Industry News;journal;16188276;0,100;Q4;2;46;70;41;0;64;0,00;0,89;Germany;Biocom AG;2006-2013;"Biotechnology (Q4); Drug Discovery (Q4)"
554;21797;Farmaceutisch Tijdschrift voor Belgie;journal;07712367;0,100;Q4;3;15;42;139;0;39;0,00;9,27;Belgium;Algemene Pharmaceutische Bond;1978-2013;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
555;21798;Farmaceutski Glasnik;journal;00148202;0,100;Q4;5;17;48;404;1;48;0,00;23,76;Croatia;Hrvatsko Farmaceutsko Drustvo/Croatian Pharmaceutical Society;1950-1951, 1962, 1990-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
556;21800;Farmacevtski Vestnik;journal;00148229;0,100;Q4;4;30;81;647;0;80;0,00;21,57;Slovenia;Slovensko Farmacevtsko Drustvo;1961, 1989-2016 (cancelled);"Pharmaceutical Science (Q4); Pharmacology (Q4)"
557;11800154521;ICBPE 2006 - Proceedings of the 2006 International Conference on Biomedical and Pharmaceutical Engineering;conference and proceedings;00002006;0,100;-;8;0;124;0;8;123;0,07;0,00;United States;;2006;"Biomedical Engineering; Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
558;19700174971;Indian Journal of Forensic Medicine and Toxicology;journal;09739122, 09739130;0,100;Q4;18;29;43;369;2;43;0,06;12,72;India;Aall India Institute of Medical Sciences;2008-ongoing;"Health, Toxicology and Mutagenesis (Q4); Law (Q4); Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
559;4900152705;NATO Security through Science Series A: Chemistry and Biology;book series;18714641;0,100;Q4;12;148;51;2649;1;50;0,02;17,90;Germany;Springer Verlag;2006-2008;"Biotechnology (Q4); Chemistry (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
560;86349;Oral Therapeutics and Pharmacology;journal;02881012;0,100;Q4;5;9;40;155;0;40;0,00;17,22;Japan;Shika Yakubutsu Ryoho Kenkyukai;1984-ongoing;"Dentistry (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
561;72755;Phytomedica;journal;09723293;0,100;Q4;4;15;55;208;1;55;0,00;13,87;India;Scientific Publishers;1999-2006;"Complementary and Alternative Medicine (Q4); Pharmacology (Q4)"
562;5800207507;Side Effects of Drugs Annual;book series;03786080;0,100;Q4;5;51;101;3531;1;52;1,00;69,24;Netherlands;Elsevier BV;1977-1995, 1997-2005, 2007-ongoing;"Drug Guides (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
563;21100239606;Therapeutic Innovation and Regulatory Science;journal;21684790;0,100;Q4;12;0;102;0;0;98;0,00;0,00;United States;SAGE Publications Inc.;1970, 1972, 1974-2006, 2008-2011, 2013-ongoing;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4); Public Health, Environmental and Occupational Health (Q4)"
564;12000154522;Advances in Antiviral Drug Design;book series;10758593;;-;11;7;0;624;0;0;0,00;89,14;United States;JAI Press;1996, 1999, 2003, 2007;"Infectious Diseases; Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous); Virology"
565;5400152620;American Journal of Pharmacology and Toxicology;journal;15574970, 15574962;;-;16;21;0;581;0;0;0,00;27,67;United States;Science Publications;2007-2016 (cancelled);"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
566;9800153152;Archivos Venezolanos de Farmacologia y Terapeutica;journal;07980264;;-;4;26;0;874;0;0;0,00;33,62;Venezuela;Tribuna Medica Venezolana;2007-2013, 2015-ongoing;"Pharmacology; Pharmacology (medical)"
567;5400152628;Brazilian Journal of Pharmacognosy;journal;0102695X, 1981528X;;-;37;93;0;2875;0;0;0,00;30,91;Brazil;Sociedade Brasileira de Farmacognosia;2007-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
568;21100829255;Chinese Journal of Pharmaceutical Biotechnology;journal;10058915;;-;4;105;0;1399;0;0;0,00;13,32;China;China Pharmaceutical University;2007-ongoing;"Applied Microbiology and Biotechnology; Pharmaceutical Science"
569;5800173401;Current Bioactive Compounds;journal;15734072;;-;21;17;0;1782;0;0;0,00;104,82;United Arab Emirates;Bentham Science Publishers;2007-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
570;19500157062;Current Cardiovascular Risk Reports;journal;19329563, 19329520;;-;23;69;0;2328;0;0;0,00;33,74;United States;Current Medicine Group;2007-ongoing;"Pharmacology; Pharmacology (medical)"
571;5800173394;Current Drug Therapy;journal;15748855;;-;14;30;0;2159;0;0;0,00;71,97;United Arab Emirates;Bentham Science Publishers;2007-ongoing;"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
572;13000154717;Current Topics in Toxicology;journal;09728228;;-;6;7;0;326;0;0;0,00;46,57;India;Research Trends;2007-2009, 2011-ongoing;"Health, Toxicology and Mutagenesis; Toxicology"
573;19700174893;Dhaka University Journal of Pharmaceutical Sciences;journal;18161839, 18161820;;-;10;26;0;310;0;0;0,00;11,92;Bangladesh;University of Dhaka;2007-ongoing;"Pharmaceutical Science; Pharmacology (medical)"
574;11200153563;Drug Metabolism Letters;journal;18723128;;-;23;52;0;105;0;0;0,00;2,02;United Arab Emirates;Bentham Science Publishers;2007-ongoing;"Biochemistry (medical); Clinical Biochemistry; Pharmaceutical Science; Pharmacology (medical)"
575;10600153336;Innovations in Pharmaceutical Technology;trade journal;14717204;;-;6;72;0;241;0;0;0,00;3,35;United Kingdom;Samedan Pharmaceutical Publishers Ltd.;2007-2010, 2012-ongoing;Pharmaceutical Science
576;6800153106;International Journal of Essential Oil Therapeutics;journal;19614209;;-;10;32;0;1041;0;0;0,00;32,53;France;Essential Oil Resource Consultants;2007-2010;"Complementary and Alternative Medicine; Pharmaceutical Science; Pharmacology (medical)"
577;21100301409;Issues in Toxicology;book series;17577179;;-;12;26;0;1135;0;0;0,00;43,65;United Kingdom;Royal Society of Chemistry;2007-ongoing;"Health, Toxicology and Mutagenesis; Pharmacology; Toxicology"
578;11700154733;Journal of Biomedical Nanotechnology;journal;15507033;;-;64;48;0;1910;0;0;0,00;39,79;United States;American Scientific Publishers;2007-ongoing;"Bioengineering; Biomedical Engineering; Materials Science (miscellaneous); Medicine (miscellaneous); Nanoscience and Nanotechnology; Pharmaceutical Science"
579;94365;Journal of Phytomedicine and Therapeutics;journal;11181028;;-;5;9;0;180;0;0;0,00;20,00;Nigeria;National Institute for Pharmaceutical Research and Development;2000-2003, 2007, 2009;Pharmacology
580;21100874234;Latin American Journal of Pharmacy;journal;23623853, 03262383;;-;17;138;0;3339;0;0;0,00;24,20;Argentina;Colegio de Farmaceuticos de la Provincia de Buenos Aires;2007-ongoing;"Drug Discovery; Pharmaceutical Science"
581;24071;Metal-Based Drugs;journal;07930291, 16875486;;-;33;5;0;133;0;0;0,00;26,60;Egypt;Hindawi Publishing Corporation;1996-2002, 2007-2011;"Drug Discovery; Inorganic Chemistry; Pharmacology; Toxicology"
582;5400152706;Nanotoxicology;journal;17435390, 17435404;;-;72;26;0;1367;0;0;0,00;52,58;United Kingdom;Informa Healthcare;2007-ongoing;"Biomedical Engineering; Nanoscience and Nanotechnology; Toxicology"
583;19700175819;Patient Preference and Adherence;journal;1177889X;;-;37;19;0;599;0;0;0,00;31,53;New Zealand;Dove Medical Press Ltd;2007-ongoing;"Health Policy; Medicine (miscellaneous); Pharmacology, Toxicology and Pharmaceutics (miscellaneous); Social Sciences (miscellaneous)"
584;5900153315;Pharmacoeconomics - Spanish Research Articles;journal;1695405X;;-;5;15;0;441;0;0;0,00;29,40;Switzerland;Springer International Publishing AG;2007-ongoing;"Health Policy; Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
585;5800179590;Pharmacologyonline;journal;18278620;;-;21;136;0;3336;0;0;0,00;24,53;Italy;SILAE;2007-ongoing;"Drug Discovery; Pharmacology"
586;21243;Pharmacy times;trade journal;00030627;;-;8;244;0;1502;0;0;0,00;6,16;United States;Romaine Pierson Publishers;1947-1949, 1975, 1977-1987, 2007-ongoing;"Pharmaceutical Science; Pharmacology; Pharmacy"
587;11900154404;PLoS Neglected Tropical Diseases;journal;19352727, 19352735;;-;110;43;0;1149;0;0;0,00;26,72;United States;Public Library of Science;2007-ongoing;"Infectious Diseases; Pharmacology, Toxicology and Pharmaceutics (miscellaneous); Public Health, Environmental and Occupational Health"
588;11500153306;Recent Patents on Drug Delivery and Formulation;journal;18722113;;-;25;21;0;1595;0;0;0,00;75,95;United Arab Emirates;Bentham Science Publishers;2007-ongoing;"Biomedical Engineering; Medicine (miscellaneous); Pharmaceutical Science"
589;11400153335;Recent Patents on Inflammation and Allergy Drug Discovery;journal;1872213X;;-;21;28;0;2149;0;0;0,00;76,75;United Arab Emirates;Bentham Science Publishers;2007-ongoing;"Drug Discovery; Immunology and Allergy; Medicine (miscellaneous)"
590;10300153375;Taiwan Pharmaceutical Journal;journal;10161015;;-;5;25;0;417;0;0;0,00;16,68;Taiwan;Pharmaceutical Society of Taiwan;2007, 2009;"Pharmaceutical Science; Pharmacology"
591;9800153137;Trastornos Adictivos;journal;15750973;;-;8;32;0;799;0;0;0,00;24,97;Spain;Elsevier Doyma;2007-2012;"Pharmacology; Psychiatry and Mental Health"
592;22358;U.S. Pharmacist;journal;01484818;;-;7;171;0;3307;0;0;0,00;19,34;United States;Jobson Publishing LLC;1979, 1990-1996, 2007-ongoing;"Pharmaceutical Science; Pharmacology; Pharmacy"
